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ABSTRACT OF THE DISSERTATION 
Exploring Host-Virus Interactions in Caenorhabditis Nematodes 
by 
Kevin Chen 
Doctor of Philosophy in Biology and Biomedical Sciences 
Computational and Systems Biology 
Washington University in St. Louis, 2017 
Professor David Wang, Chair 
 
Caenorhabditis elegans is a powerful model organism that has elucidated many 
biological questions in the fields of genetics, development, and neurobiology. In addition, C. 
elegans has been used in the past decade to investigate host-pathogen interactions with bacteria 
and fungi. The recent identification of nematode viruses that naturally infect C. elegans and 
Caenorhabditis briggsae provides a unique opportunity to define host-virus interactions in these 
model hosts.  
 This dissertation first explored the transcriptional response of C. elegans and C. briggsae 
to virus infection by RNA-seq.  I identified a total of 320 differentially expressed genes (DEGs) 
in C. elegans following Orsay virus infection. The DEGs were mostly genes of unknown 
function. Interestingly, many DEGs that responded to Orsay virus infection were similar to those 
induced by Nematocida parisii infection, which is a natural microsporidia pathogen of C. 
elegans that like Orsay virus infects intestinal cells. Furthermore, comparison of the Orsay virus 
DEGs in C. elegans to Santeuil virus DEGs in C. briggsae identified 58 C. elegans genes whose 
orthologs were likewise differentially expressed in C. briggsae, thereby defining an 
evolutionarily conserved response to viral infection.  
ix 
 
 A systematic effort that utilized multiple approaches from the available genetic tools was 
carried out in C. elegans to determine if the evolutionarily conserved DEGs impacted Orsay 
virus replication either positively or negatively. I found two genes that putatively interact with 
Orsay virus. The first gene was T27E7.6, a gene of unknown function, that may play an antiviral 
role. The second gene, zip-10, a nematode transcription factor, may be a proviral gene that 
facilitates Orsay virus infection. Neither gene was previously implicated in host-virus 
interactions. The identification of the virus response genes and the discovery of genes that alter 
Orsay virus infection of C. elegans provide a foundation for future studies of host virus 
interactions in this model system.  
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Chapter 1: Introduction 
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Introduction 
 
Background on C. elegans as a model organism 
 Caenorhabditis elegans is an essential model organism for many novel biological 
discoveries such as apoptosis regulating genes [1], developmental timing [2], RNA interference 
(RNAi) [3], and the development of green fluorescent protein as a biological marker [4]. One 
aspect that made C. elegans a great model organism is its biological characteristics. C. elegans is 
a small round worm (~1mm in length) that is transparent, making it great for microscopy and 
using fluorescent markers [5]. A progeny turnover of ~3 days and a fecundity of 300-350 
embryos/hermaphrodite allow expansion of animals in a short time [5]. The relative small 
amount of space needed (petri dishes) to house the animals and the cheap food source 
(Eshcerichia coli) make C. elegans an inexpensive model to maintain. Furthermore, strains can 
be frozen for long-term storage and revived when desired [5]. All these characteristics of C. 
elegans made it suitable for research in the laboratory. 
C. elegans is a genetically tractable model organism with its genome annotated. 
Hermaphrodites can self-fertilize or be crossed with males to establish strains with desired 
genotypes [5]. In addition, RNAi can be employed to knockdown genes of interest [3,6], ethyl 
methanesulfonate (EMS) can be administered to create new random mutations [7], and 
CRISPR/Cas9 homologous recombination techniques can be used to delete, insert, or modify 
desired genes [8,9]. 
 
C. elegans as a model organism for studying host-pathogen interactions 
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Caenorhabditis elegans is a model organism widely used to interrogate host-pathogen 
interactions [10,11]. In recent years, studies in C. elegans have identified genes that are essential 
for immunity against bacterial and fungal pathogens. For instance, roles for p38 MAP kinase 
[12], TGF-β [13], DAF-2/DAF-16 insulin-like receptor signaling [14], and the transcription 
factor zip-2 [15] have been established in protection against bacterial or fungal infections in C. 
elegans. In addition, multiple studies have dissected the C. elegans transcriptional response to a 
range of different pathogens including Bacillus thuringiensis[16], Pseudomonas aeruginosa and 
Staphylococcus aureas [17], Serratia marcescens, Enterococcus faecalis, Erwinia carotovora, 
and Photorhabdus luminescens [18], and fungal pathogens including Drechmeria coniospora 
[19], Harposporium sp. [20]  and Nematocida parisii [21]. There is some overlap in the 
transcriptional responses to the various bacterial and fungal infections, suggesting that C. elegans 
maintains both “pan-microbial” and “microbe-specific” repertoires of pathogen response genes 
[22]. From the transcriptionally induced genes, some functional immune response genes have 
been identified and characterized. 
 
Transcriptional profiling of viral infection in Caenorhabditis nematodes  
Much less is understood about host responses in C. elegans to viral infection, largely due 
to the lack of, until recently, a natural virus capable of infecting C. elegans. Previous studies 
using artificial viral infection conditions with vaccinia virus [23], nematode cells with vesicular 
stomatitis virus [24,25] or a transgenic virus replicon system (Flock house virus) [26] have 
demonstrated antiviral roles for the programmed cell death genes ced-3 and ced-4, and RNA 
interference (RNAi) pathways in C. elegans. With the discovery of Orsay virus, the first known 
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natural viral pathogen of C. elegans, RNAi and ubiquitin-mediated protection against viral 
infection have been described [21,27–32].  
In addition to Orsay virus, two related viruses, Santeuil and Le Blanc, were discovered in 
wild Caenorhabditis briggsae strains. Orsay virus only infects C. elegans while Santeuil virus 
and Le Blanc virus only infect C. briggsae [27,33]. All three viruses have a common tissue 
tropism and specifically infect the intestine [34]. The identification of multiple viruses that infect 
two host species that diverged ~18 million years ago affords the unique opportunity to define 
evolutionarily conserved host responses to viral infection [35]. Furthermore, C. elegans can also 
be infected specifically in the intestine by the microsporidia N. parisii [36].  Thus, host responses 
to these various microbial pathogens can be compared and contrasted. We defined the 
transcriptional response to these natural pathogens, by using high-throughput RNA sequencing 
(RNA-seq) to quantify the host mRNA levels following different microbial infections. 
Collectively, these results shed light on the host response to viral infection and provide insight 
into the larger context of antimicrobial defense in C. elegans [37]. 
 
Infection characteristics of Caenorhabditis nematode viruses 
Orsay virus infection in C. elegans reference strain N2 neither reduces the lifespan of the 
host nor causes any obvious physiological change [27]. The virus hyper-permissive strains where 
the RNAi function was compromised, also did not have shortened lifespan, but disturbance of the 
worm intestinal cells and increased Orsay virus RNA were observed [27–29]. The limited 
physiological change in the N2 strain and no lethality by the Orsay virus infection means that the 
measurement of Orsay virus replication will largely depend on molecular tools. Also, the ability 
to measure the amount of virus replication for each stage of the virus lifecycle can help dissect 
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the role of a specific host factor. To that end, the Wang lab had developed assays to measure 
Orsay virus RNA with real-time quantitative reverse transcription PCR (qRT-PCR) [27], Orsay 
virus proteins with immunofluorescence assay [34], and Orsay virus titer with an end point 
dilution assay [37].  
The model organism C. elegans has many useful genetic tools to facilitate research in the 
model organism. However, before we can utilize the full suite of genetic tools available to 
investigate the interaction between C. elegans and Orsay virus, it is essential to characterize the 
infection process better and determine the limitation of the developed assays. We defined the 
infection characteristics of multiple controls of genetic tools. Collectively, these results 
elucidated how the controls behave and helped determine the optimal infection conditions and 
interpret the experimental results.  
 
Discovery of novel host-virus interactions in C. elegans 
Using C. elegans genetics, there are two broad approaches to identify genes in the host-
virus interactions. One of the approach is the forward genetic screen that identifies causal 
mutation from chemical mutagenized animals with phenotype related to Orsay virus replication 
[39]. The other approach is a reverse genetic screen that investigates a specific set of genes 
(whole genome or a biological relevant set) and its relationship with Orsay virus replication [40].  
The specific approach taken for the current study was a reverse genetic screens of likely host-
virus interaction genes. There are multiple ways to select a biological relevant set of genes in the 
host-virus interaction, including genes under positive selection pressure [40], proteins that 
directly interacts with virus [40], and genes that responded to virus infection.   
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The prime candidates for a genetic screen were the differentially expressed genes (DEGs) 
upon virus infection [37]. More specifically, the evolutionarily conserved DEGs between C. 
elegans and C. briggsae. The overlapping response to represent an evolutionarily conserved 
process that could interacts with virus infection. We performed a comprehensive reverse genetic 
screen on the evolutionarily conserved DEGs and found two strong candidate genes that were 
involved in the host-virus interactions.   
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Abstract 
 
Background:  Caenorhabditis elegans is a powerful model organism for probing many 
biological processes including host-pathogen interactions with bacteria and fungi. The recent 
identification of nematode viruses that naturally infect C. elegans and Caenorhabditis briggsae 
provides a unique opportunity to define host-virus interactions in these model hosts.  
Results: We analyzed the transcriptional response of pathogen infected C. elegans and C. 
briggsae by RNA-seq. We identified a total of 320 differentially expressed genes (DEGs) in C. 
elegans following Orsay virus infection. The DEGs of known function were enriched for 
ubiquitin ligase related genes; however, the majority of the genes were of unknown function. 
Interestingly, many DEGs that responded to Orsay virus infection were similar to those induced 
by Nematocida parisii infection, which is a natural microsporidia pathogen of C. elegans that 
like Orsay virus infects intestinal cells. Furthermore, comparison of the Orsay virus DEGs in C. 
elegans to Santeuil virus DEGs in C. briggsae identified 58 C. elegans genes whose orthologs 
were likewise differentially expressed in C. briggsae, thereby defining an evolutionarily 
conserved response to viral infection.  
Conclusions:  The two different species C. elegans and C. briggsae, which diverged ~18 million 
years ago, share a common set of transcriptionally responsive genes to viral infection. 
Furthermore, a subset of these genes were also differentially expressed following infection by a 
eukaryotic pathogen, N. parisii, suggesting that these genes may constitute a broader pan-
microbial response to infection. 
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Introduction 
 
Caenorhabditis elegans is a model organism widely used to interrogate host-pathogen 
interactions [1,2]. In recent years, studies in C. elegans have identified genes that are essential 
for immunity against bacterial and fungal pathogens. For instance, roles for p38 MAP kinase [3], 
TGF-β [4], DAF-2/DAF-16 insulin-like receptor signaling [5], and the transcription factor zip-2 
[6] have been established in protection against bacterial or fungal infections in C. elegans. In 
addition, multiple studies have dissected the C. elegans transcriptional response to a range of 
different pathogens including Bacillus thuringiensis[7], Pseudomonas aeruginosa and 
Staphylococcus aureas [8], Serratia marcescens, Enterococcus faecalis, Erwinia carotovora, and 
Photorhabdus luminescens [9], and fungal pathogens including Drechmeria coniospora [10], 
Harposporium sp. [11]  and Nematocida parisii [12]. There is some overlap in the transcriptional 
responses to the various bacterial and fungal infections, suggesting that C. elegans maintains 
both “pan-microbial” and “microbe-specific” repertoires of pathogen response genes [13]. From 
the transcriptionally induced genes, some functional immune response genes have been 
identified and characterized. 
Much less is understood about host responses in C. elegans to viral infection, largely due 
to the lack of, until recently, a natural virus capable of infecting C. elegans. Previous studies 
using artificial viral infection conditions with vaccinia virus [14], nematode cells with vesicular 
stomatitis virus [15,16] or a transgenic virus replicon system (Flock house virus) [17] have 
demonstrated antiviral roles for the programmed cell death genes ced-3 and ced-4, and RNA 
interference (RNAi) pathways in C. elegans. With the discovery of Orsay virus, the first known 
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natural viral pathogen of C. elegans, RNAi and ubiquitin-mediated protection against viral 
infection have been described [12,18–23].  
In addition to Orsay virus, two related viruses, Santeuil and Le Blanc, were discovered in 
wild Caenorhabditis briggsae strains. Orsay virus only infects C. elegans while Santeuil virus 
and Le Blanc virus only infect C. briggsae [18,24]. All three viruses have a common tissue 
tropism and specifically infect the intestine [25]. The identification of multiple viruses that infect 
two host species that diverged ~18 million years ago affords the unique opportunity to define 
evolutionarily conserved host responses to viral infection [26]. Furthermore, C. elegans can also 
be infected specifically in the intestine by the microsporidia N. parisii [27].  Thus, host responses 
to these various microbial pathogens can be compared and contrasted. In this study, to define the 
transcriptional response to these natural pathogens, we used high-throughput RNA sequencing 
(RNA-seq) to quantify the host mRNA levels following different microbial infections. 
Collectively, these results shed light on the host response to viral infection and provide insight 
into the larger context of antimicrobial defense in C. elegans. 
 
Results 
C. elegans transcriptional response to Orsay virus infection. 
To define the transcriptional changes in C. elegans upon Orsay virus infection, we 
compared RNA-seq results from infected and non-infected animals. We analyzed both the 
laboratory reference strain N2 as well as the rde-1 mutant, which bears a mutation in the 
Argonaut protein RDE-1 that is part of the RNAi pathway. The rde-1 mutant sustains higher 
levels of Orsay virus replication and accumulate ~100-fold more viral RNA compared to N2 [18] 
enabling us to assess the impact of more robust viral infection levels, as well as a defective RNAi 
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pathway, on the transcriptional response. Samples were analyzed at 12 hours post infection (hpi), 
a time by which Orsay virus protein expression is observed in most rde-1 animals [25]. We used 
the edgeR package [28] to identify differentially expressed genes (DEGs) in both N2 and rde-1 
strains (n= 3 replicates for each, FDR < 0.05, Table 2.1). The vast majority of the DEGs were 
up-regulated, while a small subset of DEGs were down-regulated (Table 2.1, Supplementary 
Figure 2.1). Among the induced genes, up-regulation ranged between 1.8-fold to over 1000-fold 
compared to mock control (Supplementary Figure 2.1, Supplementary Table 2.1 & 2.2).  
 
 
Figure 2.1. C. elegans differentially expressed genes upon different pathogen infections. A) 
Venn diagrams showed the number of genes as differentially expressed after 12-hour infection 
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for the three different conditions (Orsay virus [N2], Orsay virus [rde-1], and N. parisii [N2]) and 
their relationships. B) Bar graph showed the number of genes as up-regulated or down-regulated 
upon different infections.  
 
Table 2.1. The number of C. elegans differentially expressed genes (DEGs) upon different 
pathogen infection 
  
Orsay virus 
[N2] 
Orsay virus 
[rde-1] 
N. parisii 
[N2] 
DEGs UP 129 277 185 
DEGs DOWN 1 21 11 
DEGs Shared with Orsay virus [N2] N/A 108 108 
DEGs shared with Orsay virus [rde-1] 108 N/A 139 
Differentially expressed genes were analyzed using edgeR with 3 replicates and a FDR < 0.05 
cutoff. N/A: Not applicable. 
 
Between the two different strains of C. elegans, there were 108 DEGs shared, while there 
were 22 and 190 DEGs specific to N2 and rde-1, respectively (Figure 2.1). The majority of the 
DEGs were of unknown functions. For the subset that had annotations, we identified several 
enriched gene families and functions using the software package DAVID [29,30], (FDR<0.05, 
Table 2.2). Both N2 and rde-1 DEGs were enriched for several gene families including DUF38 
domain genes, DUF713 domain genes, MATH (meprin-associated Traf homology) domain genes 
and a family of paralogs exemplified by C17H1.3 (C17H1 family genes hereafter, named after 
the C17H1 locus which contains the largest number of genes in this family) (Table 2.2). The 
C17H1 family genes have an ortholog in humans, Amyotrophic Lateral Sclerosis 2 Chromosome 
Region Candidate 12 (ALS2CR12) which encodes a protein of unknown function. Most of the 
DUF38 domain containing genes also contain an F-BOX domain, which is associated with the 
ubiquitin ligase pathway. The DUF713 domain genes are specific to the Caenorhabditis genus 
and do not have any associated functions. Of the 22 DEGs that were specific to N2 infected with 
Orsay virus, no statistically enriched gene families were identified. Of the 190 rde-1 specific 
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DEGs, there were several additional enriched gene families including CUB-like domain genes, 
CUB domain genes, and zinc finger (C6HC-type) domain genes. In addition, innate immune 
response genes were enriched based on GO annotation (Table 2.2). For the DEGs that were 
shared between the two strains, rde-1 DEGs in general were induced to a greater degree 
(Supplementary Figure 2.1, Supplementary Table 2.1 & 2.2). 
To confirm the RNA-seq results, we used quantitative real-time reverse transcription 
PCR (qRT-PCR) of an independent Orsay virus infection in the N2 strain to evaluate transcript 
levels of three highly up-regulated genes (C17H1.3, C17H1.8, and F26F2.1) and two genes that 
did not change following viral infection (B0024.4 and tsp-1). All five genes yielded similar 
results between transcriptional profiling and qRT-PCR (Supplementary Figure 2.2).  
 
Table 2.2. Gene Ontology (GO), InterPRO term enriched from C. elegans genes 
differentially expressed upon Orsay virus or N. parisii infection 
Condition 
Go term, InterPRO 
classification 
Human 
ortholog
Functional 
annotations 
Gene 
count FDR 
Orsay virus 
[N2] 
IPR026674:ALS2CR12 
protein (C17H1 family) 
Yes N/A 
 24 6.9E-32
  IPR002900:DUF38 
No F-box 
associated 13 6.6E-09
  IPR007883:DUF713 No N/A 5 1.4E-06
  IPR002083:MATH Yes MATH 8 1.3E-06
  
Orsay virus 
[rde-1] 
IPR026674:ALS2CR12 
protein (C17H1 family) 
Yes N/A 
25 2.3E-25
  
GO:0045087:Innate immune 
response 
N/A Innate 
immunity 23 6.2E-13
  IPR002083:MATH Yes MATH 14 3.1E-09
  IPR007883:DUF713 No N/A 7 2.9E-08
  IPR002900:DUF38 
No F-box 
associated 16 3.8E-06
  IPR003366:CUB-like domain No N/A 9 4.7E-06
  IPR000859:CUB domain Yes CUB 8 6.1E-04
  
IPR002867:Zinc finger, 
C6HC-type 
Yes Ubiquitin 
related 4 2.1E-02
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N. parisii 
[N2] 
IPR026674:ALS2CR12 
protein (C17H1 family) 
Yes N/A 
25 1.4E-29
  IPR007883:DUF713 No N/A 9 1.7E-14
  IPR002083:MATH Yes MATH 11 3.0E-08
  IPR002900:DUF38 
No F-box 
associated 13 2.5E-06
  
GO:0045087:Innate immune 
response 
N/A Innate 
immunity 8 5.2E-03
  
IPR001841:Zinc finger, RING-
type 
Yes Zinc finger 
8 5.9E-03
  IPR016186:C-type lectin-like 
Yes C-type lectin-
like 9 1.0E-02
  GO:0005764:lysosome N/A lysosome 4 2.9E-02
GO term, InterPRO classification enrichment was analyzed using online DAVID Bioinformatics 
Resources 6.8. Bold denotes conserved terms across the three infection conditions: Orsay virus 
[N2], Orsay virus [rde-1], and N. parisii [N2]. N/A: Not applicable. 
 
Orsay virus and N. parisii induced a shared transcriptional response. 
Because the microsporidia N. parisii is also an intracellular pathogen of intestinal cells in 
C. elegans, we performed a parallel transcriptional profiling of N. parisii infection in N2. There 
were 196 DEGs identified in N2 at 12 hpi of N. parisii (edgeR, n= 3 replicates, FDR < 0.05, 
Table 2.1, Supplementary Table 2.3); notably 108 DEGs were shared with Orsay virus infection 
of N2 (Figure 2.1, Table 2.1). Thus, the majority of the Orsay virus induced DEGs in N2 were 
also differentially expressed following N. parisii infection. Another 33 DEGs were shared 
between N. parisii infection of N2 and Orsay infection of the rde-1 strain (Figure 2.1). 
Interestingly, only two genes were down-regulated in both rde-1 upon Orsay virus infection and 
N2 upon N. parisii infection. The two genes, pud-1.2, and pud-4, are paralogs known to be 
regulated by DAF-2, an insulin-like receptor [31,32]. Of the 55 DEGs specific to N2 infected 
with N. parisii, the enriched gene families included zinc finger (RING-type) domain genes and 
C-type lectin-like genes (Table 2.2). We compared our results with a recently published 
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expression profile of N. parisii infection, which was performed in a different genetic background 
[12],  and found the majority of the up-regulated genes that we identified were also up-regulated 
at 8 hr post infection in the previous publication (Supplementary Figure 2.3). 
 
Figure 2.2. Heatmap of transcription profiles of selected gene families with multiple 
induced family members. The heatmap showed the log2 counts per million (CPM) for each 
gene in either C17H1 gene family or DUF713 gene family. Each experimental condition had 
three replicates and each replicate was represented in a column. 
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There were four gene families enriched across all infection conditions in C. elegans: 
Orsay virus [N2], Orsay virus [rde-1], and N. parisii [N2] (Table 2.2). F-box domain genes 
(DUF38) and MATH domain genes are adapter proteins, which encode a Cullin-binding domain 
and a substrate-binding domain that target proteins for E3 ubiquitin-ligase mediated proteolysis 
[33]. There were a total of 35 unique ubiquitin ligase adaptor genes that were highly up-regulated 
(between 4-fold to 1000-fold), 8 of which were induced in all three conditions. Specifically, F-
box proteins act in concert with other proteins that are members of the Skp/Cullin/F-box (SCF) 
complex to facilitate ubiquitin-ligase mediated proteolysis. Interestingly, skr-4, a SCF complex 
gene was up-regulated in all three infection conditions. Furthermore, in the rde-1 Orsay virus 
infected condition, two additional SCF complex genes skr-5 and cul-6 were up-regulated.  
The C17H1 family genes and DUF713 domain genes have no known functions. For both 
the C17H1 family genes and DUF713 domain genes, more than 50% of the family members 
were differentially expressed. The C17H1 gene family has a total of 36 members in C. elegans, 
and of those the same 25 members (except for F22G12.7 in Orsay virus [N2] condition that was 
not statistically significant) were up-regulated following both Orsay virus and N. parisii infection 
(Figure 2.2, Table 2.2). The DUF713 domain genes have a total of 10 members in C. elegans and 
have from 5 to 9 members of the gene family up-regulated following pathogen infection (Figure 
2.2, Table 2.2). The C17H1 family had the most DEGs represented in the Orsay virus and N. 
parisii infections (Table 2.2), and some of the genes were among the highest induced with close 
to 1000-fold increase compared to mock infection. Given the highly distinct nature of Orsay 
virus from the eukaryotic microsporidium N. parisii, this shared transcriptional response may 
represent a cellular stress pathway in C. elegans triggered by intracellular perturbation.   
 
21 
 
Evolutionarily conserved response to viral infection in C. elegans and C. briggsae  
We next defined the DEGs in C. briggsae following Santeuil virus infection. Because the 
C. briggsae laboratory reference strain AF16 does not support Santeuil virus replication in our 
hands, we used the wild C. briggsae isolate JU1264 which we had previously demonstrated to be 
susceptible to Santeuil virus infection [18]. In C. briggsae, there were 258 DEGs following 
infection by Santeuil virus (edgeR, n = 3, FDR < 0.05, Supplementary Table 2.4). Of the 
Santeuil virus DEGs, 37 were down-regulated and 221 were up-regulated. On a technical note, 
JU1264 sequence reads were mapped to the closely related AF16 reference transcriptome; strain 
specific sequence differences may lead to incomplete mapping to some genes and thus a 
potential underestimate of the DEGs.  
To confirm the RNA-seq results, we used qRT-PCR of an independent Santeuil virus 
infection of JU1264 to evaluate transcript levels of two up-regulated genes: CBG03198, a gene 
with C. elegans orthologs that were also up-regulated, and CBG06596, an ortholog of the C17H1 
family in C. briggsae. The two genes yielded similar results between transcriptional profiling 
and qRT-PCR (Supplementary Figure 2.4).  
Approximately 60% of all genes in C. briggsae have well-defined orthologs in C. elegans 
[34]. We further compared the DEGs in C. elegans to their orthologous genes in C. briggsae. Of 
the 320 genes identified as differentially expressed in either N2 or rde-1 or both (union of N2 
and rde-1 viral infection induced DEGs), 197 have orthologs in C. briggsae. 59 of these had C. 
briggsae orthologs that were also differentially expressed following Santeuil infection (Figure 
2.3, Supplementary Table 2.5). The majority (57 of 59) of the DEGs were up-regulated in both 
species. One gene, hmit-1.1, was repressed in both the Orsay virus [rde-1] and the Santeuil virus 
[JU1264] conditions while clec-7 was repressed in Orsay virus [rde-1] and induced in Santeuil 
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virus [JU1264]. In total, there were 58 DEGs in the conserved response to viral infection. 29 C. 
elegans genes were induced in both N2 and rde-1 and had corresponding C. briggsae orthologs 
induced following Santeuil infection. These, included 14 C17H1 family genes, four DUF713 
domain genes, a gene in the RNAi pathway: C04F12.1, and a gene downstream of daf-16: dod-
23. The remaining 9 genes have no known functions.  There were two C. elegans DEGs in N2 
(but not in rde-1) whose orthologs in C. briggsae were also DEGs. These were F14F9.3, a zinc 
finger (C6HC-type) domain gene and ZK177.8, the human ortholog of which is SAMHD1, an 
antiviral gene against human immunodeficiency virus 1[35]. Finally, there were 27 C. elegans 
DEGs in rde-1 (but not N2) with corresponding C. briggsae DEGs.  6 were immune related 
genes, four were zinc finger (C6HC-type) domain genes, three were transcription factors (zip-1, 
zip-5 and zip-10), one was an RNAi related gene (sid-5) and the remainder had varying 
annotations (Supplementary Table 2.5).  
 
Figure 2.3. Evolutionarily conserved pan-microbial responsive C. elegans genes.  
C. elegans genes differentially expressed following Orsay and N. parisii infection that have 
orthologs in C. briggsae were differentially expressed. Red shading indicates C. elegans genes 
whose orthologs in C. briggsae have conserved response to Santeuil infection of C. briggsae.  
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Interestingly, the orthologs in C. briggsae of the DUF38 genes and MATH domain genes 
that responded to both Orsay virus and N. parisii infection were not differentially expressed 
following Santeuil virus infection. This suggests that the induction of F-box and MATH genes 
may be a C. elegans specific transcriptional response. (Supplementary Table 2.5). 
 
Evolutionarily conserved pan-microbial response 
 In total, 37 of the 58 conserved viral DEGs were also differentially regulated following 
N. parisii infection (Figure 2.3). Strikingly, all of the 29 DEGs that were conserved between the 
three viral infection conditions, Orsay virus [N2], Orsay virus [rde-1], and Santeuil virus 
[JU1264], were also N. parisii induced DEGs. Specifically, members of the C17H1 and DUF713 
gene families appeared to be pan-microbial response genes while the zinc finger (C6HC-type) 
gene responses were specific to viral infection (Supplementary Table 2.5). To further assess the 
potential roles of the conserved virus induced DEGs in the context of different pathogens, we 
compared our current results with previous published studies of pathogen induced host response. 
A prior microarray study of Orsay virus infection of C. elegans identified multiple DEGs [19], of 
which 24 DEGs were shared between the two studies in N2 background and 40 DEGs were 
shared in the rde-1 mutant (Supplementary Figure 2.3). In addition, we identified additional 
statistically significant viral DEGs, possibly due to the use of synchronized animals. We 
examined a panel of representative bacterial pathogens including Pseudomonas aeruginosa, 
Enterococcus faecalis, Staphylococcus aureus, Bacillus thuringiensis, Serratia marcescens, and 
Photorhabdus luminescens [7,8,11,36] and fungal pathogens including Drechmeria coniospora 
and Harposporium sp. [11]. All up-regulated and down-regulated DEGs identified from previous 
studies were compared to the up-regulated or down-regulated Orsay virus DEGs. P. aeruginosa, 
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P. luminescens and D. coniospora infection each shared a significant number of DEGs with 
Orsay virus infection (Fisher exact test p < 0.001). Notably, dod-22 was differentially expressed 
in all four instances. By contrast, there was an inverse association of E. faecalis DEGs with 
Orsay virus DEGs (Fisher exact test p < 0.001), with fewer shared DEGs than expected by 
chance. Finally, the other pathogens did not have a significant relationship with the Orsay virus 
DEGs (Table 2.3). 
We also specifically investigated the transcriptional response of the C17H1 gene family 
members following infection by other pathogens. In prior published studies, P. luminescens and 
D. coniospora each induced multiple of the virally up-regulated C17H1 gene family members 
(Table 2.3). Interestingly, some of the C17H1 family genes that were not up-regulated following 
viral infection were differentially expressed following infection by D. coniospora, 
Harposporium, P. luminescens, and S. marcescens (Table 2.3). Thus, there may be pan-microbial 
responsive C17H1 family members as well as those that respond to specific pathogens.   
 
  
Table 2.3. Conserved responses between bacterial or fungal pathogen to Orsay virus DEGs. 
  
Total 
DEGs 
Bacterial/fungal 
DEGs shared 
with Orsay 
DEGs 
Overlap 
significance 
Number of  
DEGs from 
C17H1 
family 
Number of 
C17H1 DEGs 
shared with Orsay 
virus infection 
B. thuringiensis 246 5 4.4E-01 0 0 
D. coniospora 3787 84 6.1E-04 15 11 
E. faecalis 3819 40 3.7E-03 2 2 
Harposporium 
sp. 
3695 
60 7.1E-01 
6 
4 
P. aeruginosa 146 10 1.0E-04 0 0 
P. luminescens 3797 111 6.4E-12 12 11 
S. aureus 386 9 2.1E-01 1 1 
S. marcescens 3384 56 6.5E-01 11 7 
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Pathogen infection expression profile analysis data were obtained from  [7,8,11,36]. The DEGs 
from each pathogen were compared to Orsay virus DEGs. Association significance is calculated 
using Fisher exact test. BOLD indicates a significant negative correlation.  
 
Discussion and Conclusion 
We defined the host transcriptional response to viral infection in C. elegans and C. 
briggsae. From our statistical analysis of Orsay virus infections in N2 and rde-1 mutant strains, 
we identified a total of 320 DEGs in C. elegans, of which 108 DEGs were shared. In the rde-1 
Orsay virus infection, there were more DEGs compared to infection of N2. In addition, the 
magnitude of the transcriptional changes in rde-1 was generally greater. One possible 
explanation for this observation is that the higher levels of viral infection in rde-1 may have 
created a more significant perturbation from the basal state, leading to a more robust 
transcriptional response. Alternatively, the lack of competent RNAi in rde-1 may have resulted 
in induction of a distinct, compensatory host response. One potential limitation of these studies is 
that Orsay, Santeuil, and N. parisii infection is thought to be limited to at most the 20 intestinal 
cells present in Caenorhabditis nematodes. Because our transcriptional profiling used RNA 
extracted from populations of entire animals (each C. elegans has 959 somatic cells), some 
transcriptional responses may have been masked by the basal level of transcription in the 
uninfected cells, and thus our results are likely an underestimate of the transcriptional changes 
occurring in the intestinal cells.  
Strikingly, 108 of the N2 DEGs were also differentially expressed following infection 
with the microsporidium, N. parisii (Figure 2.1). Orsay virus is a small single stranded RNA 
virus with a bipartite genome of 3.6 Kb and 2.6 Kb that is only known to encode three proteins 
[18]. By contrast, N. parisii has a 4.1 Mb genome and encodes more than 2000 genes [27,37]. 
Despite the lack of obvious similarity between these two microbes, the fact that a significant 
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fraction of the transcriptional response to these two pathogens overlapped suggests that C. 
elegans may have some form of a universal “stress response”. One clear commonality between 
the two is that they are both intracellular intestinal pathogens of C. elegans; in fact they are the 
only intracellular pathogens of C. elegans described to date. Thus, the conserved transcriptional 
response may reflect recognition of some shared intracellular perturbation.  Interestingly, 
although some of these shared response genes are potentially involved in the ubiquitin ligase 
pathway, the majority of the shared response genes are largely unannotated genes of unknown 
function. These genes could play important roles in immunity against pathogen infection. 
Alternatively, it is also possible that these genes are important for pathogen infection, and that 
the pathogen alters the transcriptional response to facilitate infection and replication. 
Many of the characterized genes induced by Orsay virus or N. parisii infection in C. 
elegans were genes in the ubiquitin ligase pathway. When challenged with either Orsay virus or 
N. parisii, there were 35 unique F-box related or MATH domain genes up-regulated. In addition, 
SCF complex genes, such as skr-4, were up-regulated in all C. elegans infections while skr-5 and 
cul-6 were up-regulated in the rde-1 mutant infected with Orsay virus. Most of the F-box and 
MATH family members have sites in their substrate binding domains that are under strong 
positive selection and are greatly expanded in C. elegans in comparison to humans [33]. This 
suggests a possible role of ubiquitin ligase as part of the C. elegans host-pathogen interaction to 
restrict pathogen proliferation. Indeed, SCF ubiquitin ligases are demonstrated as a line of 
defense against infection by Orsay virus and N. parisii in C. elegans [12]. Intriguingly, none of 
the DEGs in C. briggsae were known F-box or MATH genes, suggesting that these ubiquitin 
ligase pathways may be a specific C. elegans response.  
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There are varying degrees of conservation between Orsay virus response genes to other 
pathogens of C. elegans. We analyzed previously published transcriptional profiling studies of 
infection by 8 bacterial and fungal pathogens and identified three that have a significant fraction 
of DEGs shared with Orsay virus infection. The three pathogens, P. aeruginosa, P. luminescens 
and D. coniospora, all can affect the intestine of the worm, but each does so in unique fashion. P. 
aeruginosa PA14 primarily kills by excreted toxins, P. luminescens colonizes the intestinal 
lumen, which is characterized by the appearance of cytosolic crystalline structures of unknown 
origin [38], and D. coniospora produces threadlike hyphae that penetrate and eventually kill the 
infected animal [39]. Other pathogens that also target the intestine such as E. faecalis and S. 
aureus did not have significant DEGs in common with Orsay virus infection, demonstrating a 
specificity of the host response. The different responses of C. elegans to various pathogens 
suggest the existence of distinct sensing and regulatory mechanisms. One potential regulatory 
element in response to virus infection is drh-1, a RIG-I like protein in C. elegans. Previous 
studies have determined that drh-1 both acts directly as a effector in the RNAi pathway to restrict 
virus replication and as a sensor of virus infection critical for downstream host responses [19,20].  
Comparative analysis of the DEGs in virus infected C. elegans and C. briggsae identified 
58 C. elegans genes whose C. briggsae orthologs were also differentially expressed. Of those, 29 
were shared between the three conditions: Orsay virus [N2], Orsay virus [rde-1], and Santeuil 
virus [JU1264]. Strikingly, 14 of the 29 genes were members of a single gene family, the C17H1 
family genes in C. elegans. Induction of members of this gene family in response to viral 
infection was conserved in two divergent Caenorhabditis nematode species despite ~18 million 
years of host evolution. Furthermore, analysis of other published transcriptomes identified 
induction of C17H1 family genes by bacterial and fungal pathogens. The upregulation of a 
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subset of these genes by disparate microbes such as virus, bacteria, and fungi raises the 
possibility that this gene family may form the core of a pan-microbial stress response. To date, 
there has been no reported function associated with these family members. The large number of 
paralogs induced following Orsay virus or N. parisii infection suggests the possibility of 
functional redundancy, which would provide a challenge in experimental testing of the functions 
of these genes.  
Our transcriptional profiling study of both virus and microsporidium infection provides 
insights into the host response to pathogens. We found that distinct pathogens such as Orsay 
virus and N. parisii elicited a similar set of DEGs in C. elegans, suggesting that these DEGs may 
constitute a broad pan-microbial response to infection. Additionally, within the transcriptional 
profile of viral infection in the two different nematode species C. elegans and C. briggsae, we 
found a shared set of 58 evolutionarily conserved transcriptional responsive genes to viral 
infection, many of which have no known function. Given the fact that diverse hosts regulate 
these common genes in response to distinct viral infections suggests that they play important 
roles. Further studies are needed to define the impact and mechanism of action of these genes on 
viral infection. 
 
Materials and Methods 
Strains 
N2 and rde-1 (WM27) were obtained from the Caenorhabditis Genetics Center (CGC). Isolation 
of wild C. briggsae strains JU1264 has been described [18]. 
 
Infectious virus filtrate preparation 
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Orsay virus and Santeuil virus were propagated as previously described [18]. Briefly, C. elegans 
rde-1 mutants were subjected to Orsay virus infection. C. briggsae JU1264 were subjected to 
Santeuil virus infection. Infected animals were subsequently collected and homogenized. The 
homogenate were passed through a 0.22 μm filter to obtain filtered viruses. 
 
Quantification of virus titer  
To measure the infectious titer of viruses, we employed a method similar to tissue culture 
infectious dose 50% (TCID50) using live C. elegans or C. briggsae in wells instead of cultured 
cells. We were not able to measure killing of nematodes as none of the viruses were lethal. To 
measure infectivity in a well, we used qRT-PCR to determine whether replication of viral RNA 
occurred, using a criterion of Ct value of 30 and below as positive infection.  Animals were 
synchronized and plated on 6-well plate seeded with 20 l OP50 food. Virus filtrates were 
serially diluted 10-fold to 10-8. 20 l of each dilution were added to a well containing animals 
and combined to have four total replicates per condition. Infected animals were incubated at 
20°C for three days and collected into Trizol. RNA samples were extracted using Zymo 96-well 
RNA extraction kit.  The stock Orsay virus filtrate had a titer of 2.3 x 106 TCID50/ml and 
Santeuil virus a titer of 8.9 x 106 TCID50/ml. 
 
Pathogen inoculation 
Three independent infections were conducted for each strain and pathogen. Two methods were 
used to infect animals. 1) Uninfected C. elegans (N2 and rde-1) and C. briggsae (wild isolate 
JU1264) were synchronized by standard bleach treatment. 2,000 embryos were seeded per well 
into 6-well NGM plates containing 20 μl of OP50 food and maintained at 20°C. For each 
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condition, 18 wells were prepared and collected. 39 hours after bleaching, animals (L3 stage) 
were inoculated with 20 μl of Orsay virus (4.0 x 105 TCID50 /ml) for C. elegans or Santeuil virus 
(8.9 x 105 TCID50/ml) for C. briggsae, or M9 buffer as control. 12 hours post infection, animals 
were rinsed off from the wells with 1 ml M9 buffer, supernatant were removed after 
centrifugation and 1 ml Trizol were added. 2) Uninfected C. elegans (N2 and rde-1) were 
synchronized by standard bleach treatment and 20,000 embryos were added to 10 cm NGM 
plates seeded with 1.5 ml of OP50. 39 hours after bleaching, animals (L3 stage) were inoculated 
with either 200 μl Orsay virus (4.0 x 105 TCID50 /ml), N. parisii microsporidia (10,000 
spores/animal), or homogenates of uninfected rde-1 passed through a 0.22 µm pore filter (mock 
control). C. briggsae (JU1264) were treated similarly and infected with 200 μl Santeuil (8.9 x 
105 TCID50/ml) virus. Animals were rinsed off from the plates and harvested in Trizol at 12 
hours after exposure to virus, microsporidia, or mock control.  
 
Preparation of RNA-seq sample 
Total RNA was extracted using Trizol and mRNA was subsequently enriched using OligoTex 
mRNA mini (Qiagen) according to the manufacturer’s protocol. RNA concentrations were 
assessed by Qubit fluorimeter (Life Technologies) and 10-100 ng of each sample were sent to 
Genome Technology Access Center in the Department of Genetics at Washington University 
School of Medicine (GTAC) for RNA-Seq. 
 
RNA-Seq Analysis 
Illumina HiSeq platform-generated single end reads of 50bp were aligned to N2 reference strain 
and AF16 reference strain transcriptomes (WS250) with TopHat2 [40]. The aligned reads were 
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counted with HT-Seq [41]. Only uniquely aligned reads were counted and used for downstream 
analysis. The read counts were processed with R package edgeR [28,42] . Samples were 
subjected to batch effect adjustment as there were two different methods of preparation and all 
three replicates were independently conducted on different days. The resulting counts were 
subjected to standard edgeR differential expressed gene analysis with a statistical cutoff of FDR 
< 0.05.  
 
Real time quantitative two-step RT-PCR (qRT-PCR) of host genes  
1 µg of total RNA from each sample was treated with DNaseI (Fermentus) according to the 
manufacture’s protocol, purified using an RNeasy kit (Invitrogen) and then eluted in 20 µl 
RNase/DNase free water.  cDNA synthesis was performed by using an oligo(dT) primer with  
thermoscript reverse transcriptase (Thermo Scientific) at 65 °C for 45 minutes. The synthesized 
cDNA was diluted 1:10 and 5 ul of the diluted cDNA was used for real time-qPCR. Real time 
qPCR was performed using Taqman qPCR master mix reagents (Applied Biosystem) on a ViiA7 
real time PCR system (Applied Biosystem) following the manufacturer’s suggested protocol. 
Each analyzed gene was normalized to an internal control cdc-42 gene and expressed as fold 
change of infected samples compared to mocked infected samples. 
 
Association of bacterial or fungal pathogen DEGs with Orsay virus DEGs 
The significance of association between bacterial or fungal DEGs from previous studies and 
Orsay virus DEGs was measured by a Fisher exact test. Briefly, concordant (up-regulated in both 
or down-regulated in both) DEGs between a selected pathogen and Orsay virus were counted as 
the overlapped DEGs. Fisher exact test was calculated with the total non-overlapped pathogen 
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DEGs, the non-overlapped Orsay virus DEGs and all other remaining genes (non-differentially 
expressed following bacterial, fungal or viral infection). Pair-wise comparison between 
pathogens DEGs against Orsay RNA were done for all pathogens.  
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Supplementary Materials 
 
 
Supplementary Figure 2.1 Heatmap of differentially expressed genes upon pathogen 
infections. The heatmap showed the expression level for all of the differentially expressed genes 
in the three infection conditions (Orsay virus [N2], Orsay virus [rde-1], and N. parisii [N2]). A) 
Log2 CPM of each gene presented. B) Median normalized Log2 CPM of each gene. Each CPM 
value was normalized to the median CPM for the given gene. Each experimental condition had 
three replicates and each replicate was represented in a column. Samples that did not have 
measurable expression were grey.  
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 Supplementary Figure 2.2 Confirmation of C. elegans RNA-seq with qRT-PCR. Expression 
of N2 response genes to Orsay virus infection with RNA-seq was confirmed with qRT-PCR. 
qRT-PCR results were normalized to cdc-42 before calculating fold-change.  
 
40 
 
 Supplementary Figure 2.3 Comparison of DEGS with previous publications. Venn diagrams 
showed the comparison of DEGs from our current study to previous published studies. A) 
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Comparison of up-regulated DEGs from N. parisii [N2] infection. The most similar conditions 
from Bakowski et al. were used (8 hours and 16 hours post N. parisii infection). B) Comparison 
of up-regulated genes in N2 after Orsay virus infection between current study and Sarkies et al. 
C) Comparison between down-regulated genes in N2 after Orsay virus infection between current 
study and Sarkies et al. D) Comparison between up-regulated genes in rde-1 after Orsay virus 
infection between current study and Sarkies et al.  E) Comparison between down-regulated genes 
in rde-1 after Orsay virus infection between current study and Sarkies et al. 
 Supplementary Figure 2.4 Confirmation of C. briggsae RNA-seq with qRT-PCR. 
Expression level from RNA-seq of JU1264 response genes to Santeuil virus infection was 
confirmed with qRT-PCR. qRT-PCR results were normalized to cbr-cdc-42 before calculating 
fold-change. 
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Supplementary Table 2.1. List of differentially expressed genes upon pathogen infections 
(Orsay [N2]) identified by edgeR. 
WormBase Gene ID Gene Name Sequence Name Fold-change (log2) FDR 
WBGene00009168  F26F2.3 8.37 6.06E-127 
WBGene00009169  F26F2.4 7.79 4.09E-116 
WBGene00018345  F42C5.3 6.49 9.12E-90 
WBGene00009061  F22G12.1 6.18 2.05E-83 
WBGene00045401 eol-1 T26F2.3 6.06 2.32E-79 
WBGene00007659  C17H1.6 6.72 2.47E-65 
WBGene00219309  F26F2.13 5.86 2.52E-62 
WBGene00008067  C43D7.4 9.99 1.22E-61 
WBGene00044708  C17H1.13 7.09 6.47E-61 
WBGene00009170  F26F2.5 7.45 1.64E-58 
WBGene00007134  B0284.4 8.31 8.32E-55 
WBGene00009166  F26F2.1 5.54 2.18E-50 
WBGene00195165  F57G4.11 7.10 4.09E-50 
WBGene00007660  C17H1.7 4.09 9.08E-50 
WBGene00008068 sdz-6 C43D7.5 5.63 2.52E-47 
WBGene00012091  T27E7.6 6.73 4.99E-41 
WBGene00007662  C17H1.9 5.51 3.45E-40 
WBGene00008301 dct-3 C54D10.7 4.14 7.06E-37 
WBGene00007656  C17H1.3 5.86 1.90E-36 
WBGene00138721  C54D10.14 3.92 8.01E-34 
WBGene00008069  C43D7.7 8.85 1.39E-32 
WBGene00015225  B0507.8 6.45 4.01E-31 
WBGene00008267  C53A5.9 5.29 5.72E-31 
WBGene00015834 math-5 C16C4.10 6.19 1.05E-26 
WBGene00021081  W08A12.4 5.00 1.02E-24 
WBGene00020357  T08E11.1 4.52 2.26E-24 
WBGene00044014  F15H10.10 8.09 4.79E-24 
WBGene00022476 fbxa-75 Y119D3A.1 8.33 5.88E-23 
WBGene00023483  Y75B8A.39 4.11 3.32E-22 
WBGene00012726  Y39G8B.5 4.53 1.83E-20 
WBGene00007661  C17H1.8 5.73 2.07E-20 
WBGene00194645  Y105C5A.1269 4.96 1.21E-18 
WBGene00008302  C54D10.8 3.61 2.20E-18 
WBGene00008269  C53A5.11 4.80 5.62E-18 
WBGene00015227  B0507.10 5.80 1.41E-17 
WBGene00086568  Y2H9A.6 3.62 2.65E-17 
WBGene00007655  C17H1.2 6.01 9.95E-17 
WBGene00086560  ZK355.8 3.88 1.07E-16 
WBGene00044709  C17H1.14 5.11 2.38E-16 
WBGene00007657  C17H1.4 5.53 4.06E-15 
WBGene00004149 trpl-5 T16A1.7 4.23 8.72E-15 
WBGene00007132  B0284.2 3.82 3.17E-14 
WBGene00018353 fbxa-182 F42G2.4 2.32 3.63E-14 
WBGene00044237  C17H1.10 3.66 5.01E-14 
WBGene00009908  F49H6.5 4.45 6.43E-14 
WBGene00017214  F07E5.9 6.10 1.28E-13 
WBGene00013634  Y105C5A.9 3.22 8.78E-13 
WBGene00012910  Y46G5A.20 1.69 1.09E-12 
WBGene00020228  T05A8.2 6.97 6.28E-12 
WBGene00010821  M01G12.7 4.53 2.23E-11 
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WBGene00022550 droe-8 ZC196.6 3.45 1.42E-10 
WBGene00015835 math-6 C16C4.11 5.13 1.31E-09 
WBGene00194646  Y105C5A.1270 2.41 2.25E-09 
WBGene00194902  Y39H10B.3 3.23 3.23E-09 
WBGene00044711  C17H1.11 4.19 5.92E-09 
WBGene00013294  Y57G11B.1 2.96 7.22E-09 
WBGene00015223  B0507.6 2.74 7.37E-09 
WBGene00050906  F20E11.17 6.36 3.06E-08 
WBGene00015829 math-15 C16C4.5 2.02 3.25E-08 
WBGene00045393  F26D11.13 3.22 4.27E-08 
WBGene00010206  F57G4.1 6.18 6.60E-08 
WBGene00044416  C08E3.15 6.13 2.81E-07 
WBGene00015224  B0507.7 3.22 6.24E-07 
WBGene00008507  F01G10.4 4.79 1.01E-06 
WBGene00015833 math-17 C16C4.9 5.90 1.44E-06 
WBGene00015832 math-16 C16C4.8 5.84 2.77E-06 
WBGene00015828 math-14 C16C4.4 2.17 4.27E-06 
WBGene00044278  F09C6.14 5.90 4.90E-06 
WBGene00020080 math-37 R52.9 2.42 5.51E-06 
WBGene00015602 fbxa-158 C08E3.10 3.24 7.10E-06 
WBGene00045415  Y43F8B.15 3.02 7.80E-06 
WBGene00195181  F15H10.12 4.46 7.80E-06 
WBGene00044787  C54D10.12 2.37 9.67E-06 
WBGene00012399  Y6E2A.5 2.18 1.12E-05 
WBGene00007297  C04F12.1 1.56 1.24E-05 
WBGene00020637 fbxa-7 T20H9.1 5.67 1.24E-05 
WBGene00008872  F15H10.5 3.94 1.51E-05 
WBGene00012961  Y47H10A.5 1.28 3.58E-05 
WBGene00015114  B0281.8 3.69 4.44E-05 
WBGene00015839 math-10 C16C4.15 2.30 4.57E-05 
WBGene00003098 lys-9 C54C8.6 5.62 5.80E-05 
WBGene00016281  C31B8.4 3.11 6.94E-05 
WBGene00206359  C05E4.15 3.68 0.00011025 
WBGene00021179 fbxa-86 Y9C9A.12 2.80 0.0001118 
WBGene00007658  C17H1.5 5.47 0.00013353 
WBGene00009898 dod-23 F49E12.2 2.67 0.000169758 
WBGene00020361 fbxc-19 T08E11.5 3.12 0.000294736 
WBGene00022375  Y94H6A.2 1.95 0.000318747 
WBGene00018614  F48G7.2 2.41 0.000328364 
WBGene00022547  ZC196.3 3.00 0.00033229 
WBGene00022713  ZK355.3 4.01 0.000439712 
WBGene00010508  K02E2.7 3.48 0.001220132 
WBGene00004402 rom-3 Y116A8C.14 2.80 0.001304425 
WBGene00008858  F15D3.8 2.01 0.001536603 
WBGene00022673  ZK177.8 0.87 0.001708763 
WBGene00011168  R09D1.12 2.12 0.001751296 
WBGene00017112  E03H12.5 1.08 0.001751296 
WBGene00020227  T05A8.1 3.70 0.001751296 
WBGene00011539 fbxa-135 T06E6.5 2.59 0.002079804 
WBGene00004810 skr-4 Y60A3A.18 1.60 0.003822879 
WBGene00020364  T08E11.8 1.92 0.003822879 
WBGene00022708  ZK354.7 1.03 0.003822879 
WBGene00044013  F15H10.9 4.87 0.004133448 
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WBGene00009835  F47H4.2 1.26 0.005550112 
WBGene00012067 sqst-3 T26H2.5 3.27 0.005719825 
WBGene00006051 ssq-2 T28H11.5 1.42 0.006265914 
WBGene00015108  B0281.1 2.94 0.006853951 
WBGene00006053 ssq-4 T28H11.1 1.50 0.011697099 
WBGene00006050 ssq-1 K07F5.11 1.29 0.013147644 
WBGene00045457  F33H12.7 1.15 0.015304123 
WBGene00012400  Y6E2A.7 2.45 0.017681892 
WBGene00015780  C14F11.4 1.01 0.022875885 
WBGene00050899  T10C6.15 1.66 0.024159858 
WBGene00044205  T13F3.8 1.05 0.029367319 
WBGene00194713  F19B10.13 2.11 0.030164971 
WBGene00015600 fbxa-165 C08E3.8 3.01 0.030910823 
WBGene00019410  K05F1.9 1.11 0.030910823 
WBGene00012381  Y2H9A.4 1.20 0.032486674 
WBGene00020774  T24E12.5 1.17 0.032486674 
WBGene00015908  C17F3.3 0.96 0.035953625 
WBGene00016351  C33F10.1 1.12 0.037534132 
WBGene00017628  F20B6.4 -1.68 0.037534132 
WBGene00000596 col-7 C15A11.5 1.23 0.039562478 
WBGene00017466  F14F9.3 1.98 0.040997477 
WBGene00020713  T23B3.5 0.95 0.040997477 
WBGene00044207  Y6G8.5 1.78 0.040997477 
WBGene00007159  B0379.7 1.26 0.041200366 
WBGene00020116 moa-1 R155.2 1.13 0.041519784 
WBGene00010679  K08F4.5 1.07 0.044930017 
WBGene00011478  T05D4.5 1.40 0.046327869 
 
Supplementary Table 2.2. List of differentially expressed genes upon pathogen infections 
(Orsay [rde-1]) identified by edgeR. 
WormBase Gene ID Gene Name Sequence Name Fold-change (log2) FDR 
WBGene00009169  F26F2.4 14.14 4.73E-49 
WBGene00007657  C17H1.4 9.95 3.22E-45 
WBGene00008067  C43D7.4 12.63 1.88E-44 
WBGene00009168  F26F2.3 10.45 3.66E-44 
WBGene00018345  F42C5.3 9.51 1.95E-43 
WBGene00219309  F26F2.13 9.66 4.11E-43 
WBGene00007659  C17H1.6 9.56 5.33E-43 
WBGene00008269  C53A5.11 10.55 6.09E-43 
WBGene00009061  F22G12.1 8.35 3.94E-41 
WBGene00015225  B0507.8 9.07 7.16E-40 
WBGene00044708  C17H1.13 12.15 1.99E-38 
WBGene00007658  C17H1.5 8.82 3.72E-38 
WBGene00009170  F26F2.5 9.07 2.56E-37 
WBGene00195165  F57G4.11 9.04 4.34E-37 
WBGene00013634  Y105C5A.9 8.61 1.66E-36 
WBGene00007134  B0284.4 8.91 3.68E-36 
WBGene00022476 fbxa-75 Y119D3A.1 9.94 3.96E-35 
WBGene00045401 eol-1 T26F2.3 8.46 5.85E-35 
WBGene00012091  T27E7.6 9.80 1.39E-34 
WBGene00010821  M01G12.7 8.54 1.12E-32 
WBGene00021081  W08A12.4 7.36 1.48E-32 
WBGene00007662  C17H1.9 9.16 3.69E-32 
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WBGene00008068 sdz-6 C43D7.5 8.29 5.79E-31 
WBGene00007656  C17H1.3 7.88 1.01E-30 
WBGene00023483  Y75B8A.39 7.59 1.84E-30 
WBGene00044014  F15H10.10 11.30 6.02E-30 
WBGene00015227  B0507.10 8.08 8.71E-30 
WBGene00020228  T05A8.2 8.79 2.70E-29 
WBGene00044237  C17H1.10 7.55 3.89E-29 
WBGene00004149 trpl-5 T16A1.7 7.05 4.01E-29 
WBGene00007660  C17H1.7 6.51 6.23E-29 
WBGene00020357  T08E11.1 6.86 3.01E-28 
WBGene00008301 dct-3 C54D10.7 6.03 7.93E-28 
WBGene00009166  F26F2.1 7.92 6.96E-27 
WBGene00015834 math-5 C16C4.10 9.21 9.16E-27 
WBGene00138721  C54D10.14 5.88 1.11E-26 
WBGene00008267  C53A5.9 9.13 1.56E-26 
WBGene00086560  ZK355.8 6.19 1.02E-25 
WBGene00008069  C43D7.7 9.18 2.26E-24 
WBGene00015223  B0507.6 5.07 1.04E-23 
WBGene00015602 fbxa-158 C08E3.10 4.72 1.15E-20 
WBGene00012726  Y39G8B.5 7.93 1.19E-20 
WBGene00017214  F07E5.9 7.76 5.36E-20 
WBGene00194645  Y105C5A.1269 6.88 9.35E-19 
WBGene00021979  Y58A7A.5 4.68 7.09E-18 
WBGene00007132  B0284.2 6.27 1.22E-17 
WBGene00015828 math-14 C16C4.4 4.23 3.11E-17 
WBGene00016281  C31B8.4 5.24 5.05E-17 
WBGene00003092 lys-3 Y22F5A.6 5.30 7.86E-17 
WBGene00018353 fbxa-182 F42G2.4 4.08 8.53E-17 
WBGene00015833 math-17 C16C4.9 9.81 1.92E-16 
WBGene00008302  C54D10.8 5.53 2.28E-16 
WBGene00009908  F49H6.5 4.53 2.60E-16 
WBGene00009898 dod-23 F49E12.2 5.46 3.40E-16 
WBGene00044711  C17H1.11 8.44 3.50E-16 
WBGene00045393  F26D11.13 7.34 3.83E-16 
WBGene00194646  Y105C5A.1270 6.23 4.35E-16 
WBGene00022550 droe-8 ZC196.6 6.38 7.91E-16 
WBGene00008507  F01G10.4 8.12 8.46E-16 
WBGene00044709  C17H1.14 9.66 1.78E-15 
WBGene00020227  T05A8.1 9.66 5.60E-15 
WBGene00021193 math-44 Y16E11A.1 4.12 6.66E-15 
WBGene00022547  ZC196.3 6.20 7.74E-15 
WBGene00007661  C17H1.8 6.61 4.44E-14 
WBGene00013294  Y57G11B.1 7.01 9.13E-14 
WBGene00007097  B0024.4 5.43 1.14E-13 
WBGene00006627 tsp-1 C02F5.8 4.64 2.16E-13 
WBGene00050906  F20E11.17 7.47 2.16E-13 
WBGene00255420  Y51F10.15 7.52 2.28E-13 
WBGene00015832 math-16 C16C4.8 9.26 2.30E-13 
WBGene00195181  F15H10.12 9.12 4.34E-13 
WBGene00013454 fbxa-126 Y67A10A.5 8.75 5.14E-12 
WBGene00014135  ZK896.4 3.56 5.30E-12 
WBGene00219750  Y38C1AA.19 6.03 8.65E-12 
WBGene00008872  F15H10.5 7.18 1.03E-11 
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WBGene00044013  F15H10.9 9.07 1.05E-11 
WBGene00007655  C17H1.2 8.78 1.24E-11 
WBGene00045415  Y43F8B.15 4.59 1.26E-11 
WBGene00012101 zip-10 T27F2.4 4.33 1.27E-11 
WBGene00010206  F57G4.1 8.68 3.17E-11 
WBGene00044427  F56A6.5 9.10 4.01E-11 
WBGene00015114  B0281.8 8.77 5.10E-11 
WBGene00050899  T10C6.15 4.54 6.78E-11 
WBGene00202499  B0507.15 8.59 9.21E-11 
WBGene00016845  C50F7.5 3.32 1.67E-10 
WBGene00015100  B0280.2 4.16 1.74E-10 
WBGene00045475  T07A5.7 5.07 3.33E-10 
WBGene00015835 math-6 C16C4.11 8.45 3.58E-10 
WBGene00022713  ZK355.3 5.76 4.76E-10 
WBGene00235133  T26H5.14 3.28 6.19E-10 
WBGene00086568  Y2H9A.6 5.26 7.30E-10 
WBGene00044787  C54D10.12 4.42 1.09E-09 
WBGene00020080 math-37 R52.9 4.53 1.34E-09 
WBGene00022189  Y71H2AR.2 8.40 1.48E-09 
WBGene00020774  T24E12.5 3.01 1.72E-09 
WBGene00015108  B0281.1 8.48 1.89E-09 
WBGene00009077  F23B2.10 6.14 1.96E-09 
WBGene00194902  Y39H10B.3 5.11 2.00E-09 
WBGene00015226  B0507.9 5.38 2.69E-09 
WBGene00008858  F15D3.8 3.98 3.67E-09 
WBGene00044416  C08E3.15 7.97 3.67E-09 
WBGene00020637 fbxa-7 T20H9.1 6.15 3.94E-09 
WBGene00044207  Y6G8.5 4.97 4.50E-09 
WBGene00021179 fbxa-86 Y9C9A.12 5.56 9.77E-09 
WBGene00015829 math-15 C16C4.5 3.99 1.10E-08 
WBGene00015216 valv-1 B0496.7 3.10 1.28E-08 
WBGene00007694  C23H4.6 3.34 1.67E-08 
WBGene00007153 clec-41 B0365.6 2.73 1.69E-08 
WBGene00194951  Y105C5A.1274 7.88 2.00E-08 
WBGene00206359  C05E4.15 6.50 2.25E-08 
WBGene00016164  C27D9.2 3.76 2.46E-08 
WBGene00012267  W04G5.7 7.61 2.87E-08 
WBGene00044278  F09C6.14 5.26 3.04E-08 
WBGene00020364  T08E11.8 4.68 3.90E-08 
WBGene00022674  ZK177.9 5.59 7.77E-08 
WBGene00044379  F40H7.12 8.41 7.78E-08 
WBGene00045457  F33H12.7 5.52 9.13E-08 
WBGene00235311  Y57E12B.11 6.45 9.73E-08 
WBGene00011957  T23F11.6 3.59 9.82E-08 
WBGene00012961  Y47H10A.5 3.39 1.08E-07 
WBGene00010764  K10H10.9 7.52 1.15E-07 
WBGene00008602 oac-14 F09B9.1 3.13 2.02E-07 
WBGene00017422  F13C5.1 3.24 2.41E-07 
WBGene00012621  Y38H6C.8 5.52 2.63E-07 
WBGene00015839 math-10 C16C4.15 4.01 5.85E-07 
WBGene00015224  B0507.7 4.72 6.90E-07 
WBGene00022375  Y94H6A.2 3.64 8.25E-07 
WBGene00011539 fbxa-135 T06E6.5 4.78 8.77E-07 
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WBGene00015491  C05E4.12 5.15 1.25E-06 
WBGene00007297  C04F12.1 2.83 1.52E-06 
WBGene00015537  C06E4.8 4.05 1.76E-06 
WBGene00008988  F20G2.5 3.45 3.09E-06 
WBGene00004093 ppw-1 C18E3.7 2.08 3.23E-06 
WBGene00019314  K02E7.10 3.54 3.26E-06 
WBGene00004810 skr-4 Y60A3A.18 2.48 3.27E-06 
WBGene00045501  Y6G8.8 6.93 4.01E-06 
WBGene00007932 zip-5 C34D1.5 2.95 4.56E-06 
WBGene00009675  F44A6.3 6.92 5.31E-06 
WBGene00020859 bath-25 T27C10.4 4.73 5.38E-06 
WBGene00010686  K08F9.3 3.59 6.06E-06 
WBGene00001577 gem-4 T12A7.1 2.64 6.81E-06 
WBGene00013637  Y105C5A.13 2.82 6.86E-06 
WBGene00008850  F15B9.6 3.25 6.97E-06 
WBGene00012399  Y6E2A.5 3.81 7.02E-06 
WBGene00044215  ZK228.10 6.95 7.95E-06 
WBGene00195240  Y39B6A.69 5.73 8.65E-06 
WBGene00015600 fbxa-165 C08E3.8 4.68 8.70E-06 
WBGene00022869  ZK1240.4 7.22 8.81E-06 
WBGene00020220 clec-140 T05A7.2 4.04 9.06E-06 
WBGene00004811 skr-5 F47H4.10 3.86 1.13E-05 
WBGene00017839  F26G1.3 4.65 1.31E-05 
WBGene00235298  F19B6.10 5.28 1.40E-05 
WBGene00009839 fbxa-188 F47H4.8 3.43 1.63E-05 
WBGene00017705  F22E5.6 3.87 1.67E-05 
WBGene00202514  T09F5.20 5.58 2.22E-05 
WBGene00045412  C25F9.12 2.69 2.33E-05 
WBGene00012822  Y43F8B.12 3.39 2.42E-05 
WBGene00012400  Y6E2A.7 4.68 2.44E-05 
WBGene00010125 dod-22 F55G11.5 2.02 2.48E-05 
WBGene00000841 cul-6 K08E7.7 2.75 2.67E-05 
WBGene00045411  C25F9.11 3.19 3.37E-05 
WBGene00194803  C25F9.16 4.39 3.90E-05 
WBGene00044687  B0563.9 4.62 4.96E-05 
WBGene00011979  T24B8.5 3.18 5.57E-05 
WBGene00016300  C32B5.7 4.54 6.34E-05 
WBGene00012381  Y2H9A.4 2.40 7.26E-05 
WBGene00005657 srr-6 C13D9.1 2.92 8.78E-05 
WBGene00020760  T24C4.4 2.72 9.10E-05 
WBGene00003734 nhx-6 F58E1.6 4.06 1.01E-04 
WBGene00021121  W09G12.7 1.96 1.05E-04 
WBGene00022419  Y102A11A.9 2.82 1.20E-04 
WBGene00017530  F16H11.1 2.66 1.34E-04 
WBGene00006467 magu-2 C01B7.4 2.19 1.43E-04 
WBGene00007180  B0457.6 1.94 1.54E-04 
WBGene00008843 arrd-9 F15A4.9 3.85 1.71E-04 
WBGene00206393  W04G5.16 6.46 1.84E-04 
WBGene00016788  C49G7.10 2.69 1.85E-04 
WBGene00010658  K08D8.4 2.29 1.92E-04 
WBGene00008102  C44H9.7 4.07 1.94E-04 
WBGene00019349 trx-5 K02H11.6 4.90 2.29E-04 
WBGene00195177  Y43F8B.25 3.74 2.38E-04 
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WBGene00019057  F58F9.3 2.16 2.53E-04 
WBGene00022181 pho-9 Y71H2AM.16 2.10 3.21E-04 
WBGene00007506  C10C5.2 2.97 4.13E-04 
WBGene00044280  W02A2.9 1.83 4.55E-04 
WBGene00016785  C49G7.7 4.86 5.22E-04 
WBGene00011168  R09D1.12 3.46 5.23E-04 
WBGene00004400 rom-1 F26F4.3 1.96 5.91E-04 
WBGene00017467  F14F9.4 2.08 6.00E-04 
WBGene00012067 sqst-3 T26H2.5 4.90 7.64E-04 
WBGene00044206  T26H5.9 2.07 7.72E-04 
WBGene00015048 faah-2 B0218.2 1.88 7.80E-04 
WBGene00020221  T05A7.3 3.36 7.99E-04 
WBGene00005188 srg-31 T07H8.5 2.74 8.29E-04 
WBGene00045515  ZK1037.13 6.04 8.85E-04 
WBGene00022013  Y60C6A.1 3.69 8.86E-04 
WBGene00045338  M01B2.13 3.41 9.27E-04 
WBGene00022546  ZC196.2 3.25 9.67E-04 
WBGene00004402 rom-3 Y116A8C.14 3.79 1.13E-03 
WBGene00015603 fbxa-159 C08E3.11 4.65 1.14E-03 
WBGene00016763  C49A9.9 2.14 1.16E-03 
WBGene00018102 math-28 F36H5.3 3.42 1.26E-03 
WBGene00077546  C01A2.9 3.95 1.26E-03 
WBGene00008584  F08G5.6 1.75 1.33E-03 
WBGene00045416  Y37H2A.14 2.29 1.57E-03 
WBGene00008847 fbxb-102 F15A4.13 3.90 2.21E-03 
WBGene00194713  F19B10.13 4.13 2.21E-03 
WBGene00018614  F48G7.2 2.95 2.23E-03 
WBGene00017660  F21C10.11 1.57 2.33E-03 
WBGene00018209  F39G3.4 3.56 2.44E-03 
WBGene00021977  Y58A7A.3 1.68 2.45E-03 
WBGene00000503 cht-1 C04F6.3 2.22 2.54E-03 
WBGene00008679  F11A5.13 4.52 2.55E-03 
WBGene00016678  C45G9.7 2.14 2.59E-03 
WBGene00021072  W07B8.4 2.37 3.08E-03 
WBGene00020358 math-39 T08E11.2 1.75 3.78E-03 
WBGene00013837 fbxa-30 ZC47.4 3.30 3.86E-03 
WBGene00008726  F13A7.11 2.67 3.93E-03 
WBGene00020579  T19D12.4 2.33 4.18E-03 
WBGene00195084  C43C3.4 2.56 4.57E-03 
WBGene00008099  C44H9.4 2.41 4.81E-03 
WBGene00008617  F09C6.3 3.83 4.87E-03 
WBGene00008066 fbxb-65 C43D7.2 4.20 5.22E-03 
WBGene00014057  ZK673.1 -2.24 5.30E-03 
WBGene00005833 srw-86 C25F9.7 2.32 5.33E-03 
WBGene00006894 ver-1 T17A3.1 3.29 5.77E-03 
WBGene00008900  F16H6.10 2.22 5.85E-03 
WBGene00012910  Y46G5A.20 2.21 6.13E-03 
WBGene00021978  Y58A7A.4 2.80 6.19E-03 
WBGene00006628 tsp-2 C02F5.11 2.99 6.36E-03 
WBGene00017364 clec-7 F10G2.3 -3.75 6.38E-03 
WBGene00194926  K08D8.12 2.38 6.38E-03 
WBGene00015593  C08E3.1 2.93 6.63E-03 
WBGene00011052 arrd-11 R06B9.1 2.57 7.75E-03 
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WBGene00001399 fat-7 F10D2.9 -2.74 8.44E-03 
WBGene00020758  T24C4.2 2.99 8.56E-03 
WBGene00003995 pgp-1 K08E7.9 -1.75 8.81E-03 
WBGene00022570 sdz-35 ZC239.12 3.76 9.27E-03 
WBGene00015605  C08E3.13 1.98 9.28E-03 
WBGene00021236 pud-1.2 Y19D10B.7 -1.76 9.62E-03 
WBGene00007133  B0284.3 2.21 9.69E-03 
WBGene00016156  C27A12.6 1.58 9.87E-03 
WBGene00017308  F09F9.3 2.90 1.04E-02 
WBGene00044442  T08A9.13 2.56 1.06E-02 
WBGene00194708  Y36E3A.2 2.61 1.06E-02 
WBGene00014136  ZK896.5 1.48 1.20E-02 
WBGene00006649 tth-1 F08F1.8 1.53 1.24E-02 
WBGene00009130  F25H5.8 1.77 1.24E-02 
WBGene00010508  K02E2.7 3.34 1.28E-02 
WBGene00011130 zip-6 R07H5.10 2.64 1.28E-02 
WBGene00008593 clec-227 F08H9.5 -2.24 1.30E-02 
WBGene00044107  F58G6.9 -1.48 1.30E-02 
WBGene00007440  C08E8.4 1.93 1.37E-02 
WBGene00009897 skpo-1 F49E12.1 2.52 1.46E-02 
WBGene00021654  Y47G7B.2 2.39 1.46E-02 
WBGene00000136 amt-4 C05E11.5 -1.80 1.47E-02 
WBGene00020613  T20D4.7 2.62 1.47E-02 
WBGene00010977  R02D5.3 1.86 1.53E-02 
WBGene00016783 irg-2 C49G7.5 2.89 1.58E-02 
WBGene00004509 rrf-2 M01G12.12 1.65 1.60E-02 
WBGene00007216  C01A2.4 1.66 1.71E-02 
WBGene00022479 fbxa-36 Y119D3A.4 3.09 1.71E-02 
WBGene00019495 sdz-24 K07E8.3 -1.50 1.82E-02 
WBGene00009626  F42A8.1 1.35 1.88E-02 
WBGene00008793  F14D7.6 -1.51 1.94E-02 
WBGene00235315  Y50D4A.10 1.56 2.09E-02 
WBGene00017445 sid-5 F14B8.2 1.53 2.10E-02 
WBGene00010004  F53H2.1 2.51 2.12E-02 
WBGene00011945 hpo-24 T23D8.7 1.79 2.40E-02 
WBGene00013073 hmit-1.1 Y51A2D.4 -1.42 2.50E-02 
WBGene00007772 egrh-1 C27C12.2 1.53 2.50E-02 
WBGene00019368  K03H6.2 -1.58 2.54E-02 
WBGene00018385  F43C11.8 3.37 2.54E-02 
WBGene00050939  C05G5.7 -3.03 2.64E-02 
WBGene00018643 drd-50 F49F1.1 3.25 2.75E-02 
WBGene00019166 tat-2 H06H21.10 1.46 2.84E-02 
WBGene00008129  C47A10.12 -2.99 2.84E-02 
WBGene00019564  K09D9.1 2.49 2.86E-02 
WBGene00000777 cpn-1 F43G9.9 1.40 3.14E-02 
WBGene00009488 oac-20 F36G9.12 2.09 3.28E-02 
WBGene00010752  K10G4.3 2.02 3.39E-02 
WBGene00017398 slc-17.6 F12B6.2 -1.43 3.41E-02 
WBGene00008560 pho-13 F07H5.9 -1.53 3.44E-02 
WBGene00009146  F26C11.1 -1.89 3.44E-02 
WBGene00006987 zmp-1 EGAP1.3 1.54 3.61E-02 
WBGene00011850  T20B3.1 -1.68 3.62E-02 
WBGene00044707  F22G12.7 2.23 4.00E-02 
50 
 
WBGene00017498 pud-4 F15E11.12 -1.44 4.04E-02 
WBGene00018707 oac-31 F52F10.3 1.86 4.12E-02 
WBGene00006986 zip-1 Y75B8A.35 1.35 4.18E-02 
WBGene00008567  F08A8.4 -1.47 4.18E-02 
WBGene00009957  F53B2.8 1.90 4.44E-02 
WBGene00010034  F54B11.11 -1.70 4.50E-02 
WBGene00012323 oac-54 W07A12.6 2.16 4.60E-02 
WBGene00016555 math-20 C40D2.2 1.65 4.69E-02 
WBGene00014194  ZK1037.6 2.56 4.71E-02 
WBGene00019699 math-34 M01D1.2 2.66 4.75E-02 
WBGene00022548  ZC196.4 2.30 4.95E-02 
 
Supplementary Table 2.3. List of differentially expressed genes upon pathogen infections 
(N. parisii [N2]) identified by edgeR. 
WormBase Gene ID Gene Name Sequence Name Fold-change (log2) FDR 
WBGene00009169  F26F2.4 10.56 1.18E-240 
WBGene00009168  F26F2.3 10.75 4.88E-229 
WBGene00219309  F26F2.13 9.18 3.19E-163 
WBGene00195165  F57G4.11 10.49 1.92E-147 
WBGene00044708  C17H1.13 9.75 2.30E-137 
WBGene00009170  F26F2.5 10.11 4.67E-132 
WBGene00018345  F42C5.3 7.75 2.42E-127 
WBGene00007662  C17H1.9 8.34 3.40E-106 
WBGene00009061  F22G12.1 6.82 8.94E-104 
WBGene00009166  F26F2.1 8.09 1.09E-102 
WBGene00007659  C17H1.6 7.94 2.27E-95 
WBGene00045401 eol-1 T26F2.3 6.46 2.53E-92 
WBGene00007661  C17H1.8 9.87 3.36E-90 
WBGene00008067  C43D7.4 11.29 1.07E-88 
WBGene00008068 sdz-6 C43D7.5 7.37 1.01E-84 
WBGene00138721  C54D10.14 6.20 1.76E-83 
WBGene00007134  B0284.4 9.81 1.69E-82 
WBGene00012091  T27E7.6 8.91 1.70E-80 
WBGene00008301 dct-3 C54D10.7 6.11 1.15E-78 
WBGene00007660  C17H1.7 5.09 1.10E-75 
WBGene00012726  Y39G8B.5 7.54 1.15E-65 
WBGene00007656  C17H1.3 7.59 7.95E-63 
WBGene00044014  F15H10.10 10.85 4.45E-62 
WBGene00015834 math-5 C16C4.10 8.37 1.34E-58 
WBGene00194646  Y105C5A.1270 5.01 1.29E-48 
WBGene00008302  C54D10.8 5.78 2.63E-48 
WBGene00020357  T08E11.1 6.24 3.31E-48 
WBGene00015225  B0507.8 7.72 4.65E-47 
WBGene00086568  Y2H9A.6 5.70 2.32E-46 
WBGene00008267  C53A5.9 6.30 8.09E-46 
WBGene00008069  C43D7.7 9.83 2.17E-44 
WBGene00021081  W08A12.4 6.44 8.29E-43 
WBGene00194645  Y105C5A.1269 6.95 2.84E-42 
WBGene00012910  Y46G5A.20 2.96 1.38E-40 
WBGene00044709  C17H1.14 7.36 2.10E-38 
WBGene00007655  C17H1.2 8.03 1.11E-37 
WBGene00005188 srg-31 T07H8.5 4.19 1.18E-37 
WBGene00022476 fbxa-75 Y119D3A.1 9.93 3.39E-37 
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WBGene00023483  Y75B8A.39 5.22 6.49E-36 
WBGene00015835 math-6 C16C4.11 7.89 7.33E-34 
WBGene00015227  B0507.10 7.38 7.27E-31 
WBGene00017214  F07E5.9 8.42 1.56E-30 
WBGene00195181  F15H10.12 8.06 2.06E-30 
WBGene00044237  C17H1.10 5.12 6.46E-30 
WBGene00022375  Y94H6A.2 4.85 1.34E-29 
WBGene00008269  C53A5.11 6.02 1.37E-29 
WBGene00018353 fbxa-182 F42G2.4 3.19 3.22E-29 
WBGene00007674  C18D4.4 6.49 4.81E-29 
WBGene00022550 droe-8 ZC196.6 5.45 8.77E-29 
WBGene00015223  B0507.6 4.60 2.32E-28 
WBGene00020228  T05A8.2 9.32 2.51E-28 
WBGene00007657  C17H1.4 7.09 1.09E-27 
WBGene00007132  B0284.2 5.08 9.44E-26 
WBGene00010821  M01G12.7 6.32 2.13E-25 
WBGene00008872  F15H10.5 7.20 5.34E-25 
WBGene00015829 math-15 C16C4.5 3.36 2.06E-23 
WBGene00044787  C54D10.12 4.45 7.55E-23 
WBGene00015224  B0507.7 5.21 2.86E-22 
WBGene00015108  B0281.1 6.22 4.41E-22 
WBGene00015833 math-17 C16C4.9 8.60 4.42E-22 
WBGene00009908  F49H6.5 5.47 5.79E-22 
WBGene00044711  C17H1.11 6.04 1.38E-21 
WBGene00086560  ZK355.8 4.43 1.77E-21 
WBGene00015114  B0281.8 6.44 5.84E-21 
WBGene00004149 trpl-5 T16A1.7 5.08 8.84E-21 
WBGene00013294  Y57G11B.1 4.47 1.03E-20 
WBGene00044427  F56A6.5 6.80 1.52E-20 
WBGene00194902  Y39H10B.3 4.43 2.45E-19 
WBGene00015828 math-14 C16C4.4 3.62 3.27E-19 
WBGene00003098 lys-9 C54C8.6 9.41 1.32E-18 
WBGene00012399  Y6E2A.5 3.66 1.85E-18 
WBGene00050906  F20E11.17 8.31 2.25E-18 
WBGene00044013  F15H10.9 8.76 4.42E-17 
WBGene00008858  F15D3.8 3.74 5.88E-16 
WBGene00015839 math-10 C16C4.15 3.71 6.25E-16 
WBGene00010508  K02E2.7 6.14 6.44E-16 
WBGene00010206  F57G4.1 7.90 8.50E-16 
WBGene00044707  F22G12.7 3.46 1.36E-15 
WBGene00020637 fbxa-7 T20H9.1 7.88 2.39E-15 
WBGene00012400  Y6E2A.7 4.87 2.53E-15 
WBGene00206359  C05E4.15 5.79 3.52E-15 
WBGene00014046 clec-60 ZK666.6 2.17 5.93E-15 
WBGene00018614  F48G7.2 4.03 1.03E-14 
WBGene00015832 math-16 C16C4.8 7.86 1.20E-14 
WBGene00008102  C44H9.7 4.29 5.28E-14 
WBGene00011539 fbxa-135 T06E6.5 4.56 8.32E-14 
WBGene00012067 sqst-3 T26H2.5 6.02 1.65E-13 
WBGene00044207  Y6G8.5 3.87 2.57E-13 
WBGene00010004  F53H2.1 4.58 1.49E-12 
WBGene00235133  T26H5.14 3.36 2.20E-12 
WBGene00020364  T08E11.8 3.39 2.85E-12 
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WBGene00009895 scl-2 F49E11.10 3.14 3.21E-12 
WBGene00009898 dod-23 F49E12.2 3.70 9.84E-12 
WBGene00045415  Y43F8B.15 4.08 2.20E-11 
WBGene00002055 ifc-1 F37B4.2 1.51 2.37E-11 
WBGene00015222  B0507.5 3.98 3.38E-10 
WBGene00022869  ZK1240.4 5.22 3.99E-10 
WBGene00022713  ZK355.3 5.56 5.53E-10 
WBGene00017592  F19C7.2 1.25 5.73E-10 
WBGene00020227  T05A8.1 5.50 8.87E-10 
WBGene00012381  Y2H9A.4 2.18 1.04E-09 
WBGene00004810 skr-4 Y60A3A.18 2.38 1.63E-09 
WBGene00011979  T24B8.5 2.54 3.64E-09 
WBGene00043062 clec-80 Y54G2A.39 1.06 5.40E-09 
WBGene00013634  Y105C5A.9 2.90 6.87E-09 
WBGene00016281  C31B8.4 3.52 1.15E-08 
WBGene00017199 clec-45 F07C4.2 2.76 1.25E-08 
WBGene00020774  T24E12.5 2.03 3.23E-08 
WBGene00012267  W04G5.7 7.37 4.09E-08 
WBGene00020326 math-38 T07H3.3 2.78 1.10E-07 
WBGene00000781 cpr-1 C52E4.1 1.25 1.21E-07 
WBGene00045475  T07A5.7 3.03 2.19E-07 
WBGene00021193 math-44 Y16E11A.1 2.74 2.38E-07 
WBGene00045393  F26D11.13 3.20 3.27E-07 
WBGene00007658  C17H1.5 5.84 4.13E-07 
WBGene00018616  F48G7.5 1.44 4.53E-07 
WBGene00004172 pqn-92 Y75B8A.27 1.11 5.65E-07 
WBGene00012456  Y17D7C.2 2.61 8.51E-07 
WBGene00022547  ZC196.3 3.47 8.51E-07 
WBGene00007297  C04F12.1 1.58 1.04E-06 
WBGene00020080 math-37 R52.9 2.61 1.35E-06 
WBGene00015602 fbxa-158 C08E3.10 3.03 1.42E-06 
WBGene00019699 math-34 M01D1.2 2.72 2.08E-06 
WBGene00019314  K02E7.10 2.00 2.55E-06 
WBGene00012323 oac-54 W07A12.6 2.58 2.78E-06 
WBGene00219750  Y38C1AA.19 4.06 5.27E-06 
WBGene00021873 clec-82 Y54G2A.8 1.62 7.00E-06 
WBGene00195177  Y43F8B.25 2.86 7.27E-06 
WBGene00008507  F01G10.4 4.86 8.22E-06 
WBGene00012398  Y6E2A.4 2.79 1.06E-05 
WBGene00019931  R07C12.1 1.37 1.33E-05 
WBGene00050899  T10C6.15 2.26 1.59E-05 
WBGene00008850  F15B9.6 1.97 2.10E-05 
WBGene00194713  F19B10.13 2.96 2.12E-05 
WBGene00001594 glc-4 C27H5.8 1.06 2.25E-05 
WBGene00022548  ZC196.4 1.85 2.79E-05 
WBGene00020361 fbxc-19 T08E11.5 3.47 3.06E-05 
WBGene00219493  C18D4.12 3.00 4.71E-05 
WBGene00012583 clec-4 Y38E10A.5 0.89 4.83E-05 
WBGene00011330  T01D3.6 1.02 5.97E-05 
WBGene00022546  ZC196.2 2.67 7.17E-05 
WBGene00021179 fbxa-86 Y9C9A.12 2.98 9.20E-05 
WBGene00012822  Y43F8B.12 2.85 9.58E-05 
WBGene00015226  B0507.9 2.57 1.46E-04 
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WBGene00015537  C06E4.8 2.30 1.49E-04 
WBGene00016920  C54E4.5 0.92 1.49E-04 
WBGene00022870  ZK1240.5 1.54 1.51E-04 
WBGene00012093  T27E7.9 3.09 1.73E-04 
WBGene00015600 fbxa-165 C08E3.8 3.88 2.54E-04 
WBGene00009839 fbxa-188 F47H4.8 1.94 2.74E-04 
WBGene00015605  C08E3.13 2.11 2.89E-04 
WBGene00022497  Y119D3B.21 0.88 3.08E-04 
WBGene00019279  K01A2.4 1.62 3.26E-04 
WBGene00015403 clec-10 C03H5.1 0.70 4.43E-04 
WBGene00077546  C01A2.9 3.17 5.00E-04 
WBGene00219216  K08D10.14 0.97 5.85E-04 
WBGene00015052 clec-52 B0218.8 -0.91 6.50E-04 
WBGene00004402 rom-3 Y116A8C.14 3.04 6.62E-04 
WBGene00009518 clec-166 F38A1.5 1.02 7.32E-04 
WBGene00003091 lys-2 Y22F5A.5 0.69 1.24E-03 
WBGene00044416  C08E3.15 5.36 1.51E-03 
WBGene00006986 zip-1 Y75B8A.35 0.83 1.91E-03 
WBGene00022549  ZC196.5 1.07 2.08E-03 
WBGene00000391 cdd-1 C47D2.2 0.69 3.18E-03 
WBGene00010062 lipl-1 F54F3.3 1.63 3.18E-03 
WBGene00000015 abf-4 Y38H6C.22 2.86 3.49E-03 
WBGene00011168  R09D1.12 2.05 3.76E-03 
WBGene00019590  K09F6.7 0.94 4.20E-03 
WBGene00013149  Y53F4B.1 1.22 4.29E-03 
WBGene00018724  F53A9.1 0.92 4.34E-03 
WBGene00044644  B0205.13 -0.76 4.78E-03 
WBGene00021495 sqst-2 Y40C5A.1 0.65 5.03E-03 
WBGene00044278  F09C6.14 4.97 5.59E-03 
WBGene00022189  Y71H2AR.2 2.95 6.65E-03 
WBGene00013608 clec-35 Y102A5B.2 2.34 7.41E-03 
WBGene00002260 lbp-8 T22G5.6 -1.47 1.01E-02 
WBGene00004093 ppw-1 C18E3.7 0.77 1.06E-02 
WBGene00010957 nduo-6 MTCE.3 -1.08 1.24E-02 
WBGene00009397 clec-66 F35C5.9 0.67 1.34E-02 
WBGene00018354  F42G2.5 1.24 1.72E-02 
WBGene00017498 pud-4 F15E11.12 -2.24 1.74E-02 
WBGene00044206  T26H5.9 1.28 1.94E-02 
WBGene00008099  C44H9.4 1.02 2.07E-02 
WBGene00015100  B0280.2 1.17 2.22E-02 
WBGene00017501 pud-3 F15E11.15 -1.48 2.72E-02 
WBGene00001758 gst-10 Y45G12C.2 -0.63 2.97E-02 
WBGene00018645  F49F1.5 1.06 3.02E-02 
WBGene00003474 mtl-2 T08G5.10 -0.53 3.17E-02 
WBGene00016190  C28G1.5 0.58 3.28E-02 
WBGene00018346  F42C5.4 0.89 3.43E-02 
WBGene00011162 chil-19 R09D1.6 2.16 3.49E-02 
WBGene00010958 ndfl-4 MTCE.4 -1.55 3.65E-02 
WBGene00194815  Y43F8B.23 1.52 3.76E-02 
WBGene00007393 fbxa-157 C06H5.2 1.32 3.78E-02 
WBGene00021236 pud-1.2 Y19D10B.7 -2.83 4.55E-02 
WBGene00017660  F21C10.11 -1.09 4.93E-02 
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Supplementary Table 2.4. List of differentially expressed genes upon pathogen infections 
(Santeuil [JU1264]) identified by edgeR. 
WormBase Gene ID Gene Name Sequence Name Fold-change (log2) FDR 
WBGene00028845  CBG06596 7.86 8.53E-61 
WBGene00041842  CBG23492 7.17 5.69E-60 
WBGene00089186  CBG27772 6.21 3.00E-57 
WBGene00031866  CBG10486 5.91 3.74E-48 
WBGene00037928  CBG18528 5.35 9.30E-43 
WBGene00029310  CBG07170 7.56 5.63E-38 
WBGene00028206  CBG05828 4.64 1.60E-37 
WBGene00026106  CBG03198 6.34 2.06E-35 
WBGene00041841  CBG23491 5.61 3.61E-35 
WBGene00041840  CBG23490 5.47 1.39E-34 
WBGene00037931  CBG18531 4.90 2.03E-33 
WBGene00037930  CBG18530 3.44 2.71E-31 
WBGene00037932  CBG18532 5.33 5.45E-29 
WBGene00032649  CBG11544 4.12 3.53E-28 
WBGene00087844  CBG26430 5.29 5.45E-28 
WBGene00028205  CBG05827 4.72 3.29E-26 
WBGene00032650  CBG11545 3.49 1.58E-25 
WBGene00037934  CBG18534 9.06 1.82E-25 
WBGene00027499  CBG04907 7.01 1.09E-24 
WBGene00086653  CBG25239 5.91 1.09E-24 
WBGene00035660  CBG15363 4.36 1.18E-24 
WBGene00032014  CBG10726 4.84 2.54E-22 
WBGene00031174  CBG09614 4.46 2.73E-21 
WBGene00028731  CBG06463 3.86 3.62E-21 
WBGene00036071  CBG15988 5.57 5.89E-21 
WBGene00037927  CBG18525 3.98 1.32E-20 
WBGene00042629  CBG24541 3.26 4.35E-20 
WBGene00037933  CBG18533 7.17 7.09E-20 
WBGene00035828  CBG15672 4.58 9.54E-20 
WBGene00027935  CBG05495 2.78 2.36E-18 
WBGene00032552  CBG11438 2.46 3.17E-18 
WBGene00088570  CBG27156 3.46 6.31E-18 
WBGene00033706  CBG12815 2.62 4.59E-17 
WBGene00027926  CBG05483 3.75 9.20E-17 
WBGene00030380  CBG08621 3.24 1.52E-16 
WBGene00088338  CBG26924 5.60 1.87E-16 
WBGene00040743  CBG22119 3.01 2.57E-16 
WBGene00088730  CBG27316 5.60 2.79E-16 
WBGene00041839 Cbr-srh-25 CBG23489 2.83 1.67E-15 
WBGene00041311  CBG22848 2.55 2.95E-14 
WBGene00088335  CBG26921 3.85 3.51E-14 
WBGene00032537  CBG11421 2.57 4.48E-14 
WBGene00042683  CBG24613 2.81 5.34E-14 
WBGene00041674 Cbr-zip-10 CBG23294 3.00 9.93E-14 
WBGene00030420  CBG08668 2.90 7.46E-13 
WBGene00026981  CBG04270 4.32 1.01E-12 
WBGene00030571  CBG08850 3.10 1.43E-12 
WBGene00037926  CBG18524 2.55 3.20E-12 
WBGene00032652  CBG11547 3.56 4.76E-12 
WBGene00088080  CBG26666 5.02 8.71E-12 
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WBGene00028187  CBG05803 3.02 1.44E-11 
WBGene00087805  CBG26391 5.98 1.74E-11 
WBGene00038448  CBG19185 1.73 1.74E-11 
WBGene00037923  CBG18520 2.29 3.65E-11 
WBGene00038447  CBG19184 1.83 2.10E-10 
WBGene00027326  CBG04704 3.02 2.56E-10 
WBGene00088195  CBG26781 7.57 3.94E-10 
WBGene00032269  CBG11083 3.29 4.05E-10 
WBGene00027247  CBG04608 2.82 6.82E-10 
WBGene00042151  CBG23914 2.69 1.60E-09 
WBGene00042618  CBG24526 2.17 4.17E-09 
WBGene00031430  CBG09931 7.34 7.31E-09 
WBGene00031885  CBG10508 2.51 9.31E-09 
WBGene00027234  CBG04592 3.23 1.15E-08 
WBGene00088117  CBG26703 3.13 1.57E-08 
WBGene00025146  CBG01998 1.96 2.95E-08 
WBGene00087576  CBG26162 2.82 3.51E-08 
WBGene00031046  CBG09474 2.14 6.07E-08 
WBGene00031199  CBG09641 2.40 1.00E-07 
WBGene00037165  CBG17574 2.47 1.07E-07 
WBGene00039731  CBG20816 1.72 1.09E-07 
WBGene00037935  CBG18535 8.33 1.15E-07 
WBGene00026027 Cbr-clec-60 CBG03095 1.73 1.15E-07 
WBGene00028943  CBG06703 1.91 1.61E-07 
WBGene00037917  CBG18514 2.29 1.62E-07 
WBGene00026203 Cbr-thn-1 CBG03322 1.92 1.95E-07 
WBGene00031286 Cbr-nhr-6 CBG09761 1.99 2.42E-07 
WBGene00031718  CBG10309 2.08 3.03E-07 
WBGene00034684 Cbr-crn-4 CBG14049 1.66 3.66E-07 
WBGene00038787  CBG19600 4.95 4.70E-07 
WBGene00031719  CBG10310 1.87 9.69E-07 
WBGene00031134 Cbr-lys-2 CBG09573 2.45 1.18E-06 
WBGene00033703  CBG12812 1.86 1.18E-06 
WBGene00027239  CBG04600 1.77 1.41E-06 
WBGene00029282  CBG07133 4.32 1.64E-06 
WBGene00042153  CBG23916 1.71 1.90E-06 
WBGene00024645  CBG01398 1.68 2.21E-06 
WBGene00037852  CBG18425 2.11 2.82E-06 
WBGene00031720  CBG10311 1.88 3.03E-06 
WBGene00030189 Cbr-ugt-44 CBG08389 1.77 3.26E-06 
WBGene00034025  CBG13234 1.42 3.59E-06 
WBGene00038055  CBG18678 2.48 3.65E-06 
WBGene00036431  CBG16518 1.60 3.69E-06 
WBGene00039962  CBG21098 -1.27 6.34E-06 
WBGene00032201 Cbr-clec-86 CBG10980 1.75 6.97E-06 
WBGene00031750  CBG10347 2.35 8.27E-06 
WBGene00038716  CBG19512 1.89 8.27E-06 
WBGene00041843  CBG23493 1.77 8.69E-06 
WBGene00027233  CBG04591 2.57 1.35E-05 
WBGene00087737  CBG26323 1.80 1.36E-05 
WBGene00040234  CBG21474 1.96 2.65E-05 
WBGene00038450  CBG19187 1.46 3.11E-05 
WBGene00088490  CBG27076 2.33 3.21E-05 
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WBGene00041343  CBG22882 2.31 3.38E-05 
WBGene00032015  CBG10727 2.29 3.40E-05 
WBGene00030434  CBG08684 1.69 3.79E-05 
WBGene00030568  CBG08847 2.11 4.35E-05 
WBGene00032171 Cbr-sid-5 CBG10928 1.47 4.35E-05 
WBGene00036824  CBG17057 1.62 4.81E-05 
WBGene00088044  CBG26630 4.61 4.81E-05 
WBGene00038449  CBG19186 1.55 5.03E-05 
WBGene00033498 Cbr-col-56 CBG12567 2.25 5.18E-05 
WBGene00042110  CBG23863 2.08 6.01E-05 
WBGene00087765  CBG26351 1.89 6.40E-05 
WBGene00024109  CBG00772 1.59 7.92E-05 
WBGene00087767  CBG26353 1.40 8.11E-05 
WBGene00031852  CBG10468 2.09 9.31E-05 
WBGene00031865  CBG10483 1.46 9.48E-05 
WBGene00035702  CBG15433 2.73 1.06E-04 
WBGene00031687  CBG10269 1.47 1.07E-04 
WBGene00041151  CBG22628 1.69 1.51E-04 
WBGene00038823  CBG19643 1.63 1.61E-04 
WBGene00035449  CBG15117 2.71 2.15E-04 
WBGene00024304 Cbr-egl-43 CBG01007 1.36 2.49E-04 
WBGene00026507  CBG03703 1.25 2.72E-04 
WBGene00029346  CBG07223 2.15 2.76E-04 
WBGene00031666  CBG10235 1.23 2.76E-04 
WBGene00042529  CBG24409 2.54 2.76E-04 
WBGene00040475  CBG21784 1.86 3.30E-04 
WBGene00042152  CBG23915 2.22 3.30E-04 
WBGene00030567  CBG08846 1.82 3.60E-04 
WBGene00038786  CBG19599 1.22 3.60E-04 
WBGene00038268  CBG18976 1.23 3.70E-04 
WBGene00039730  CBG20815 1.28 3.75E-04 
WBGene00034762  CBG14185 -1.25 3.90E-04 
WBGene00087233  CBG25819 1.37 4.34E-04 
WBGene00039801  CBG20896 1.53 4.49E-04 
WBGene00087954  CBG26540 1.75 4.93E-04 
WBGene00030443 Cbr-ugt-51 CBG08694 -1.62 4.95E-04 
WBGene00041345  CBG22884 2.82 5.15E-04 
WBGene00029294  CBG07148 2.05 5.32E-04 
WBGene00036802  CBG17027 -1.83 5.33E-04 
WBGene00040076  CBG21241 3.21 6.34E-04 
WBGene00027285  CBG04653 2.72 8.16E-04 
WBGene00026814 Cbr-rnt-1 CBG04068 1.27 8.76E-04 
WBGene00028142  CBG05751 1.29 9.67E-04 
WBGene00034424  CBG13699 1.31 9.83E-04 
WBGene00036592  CBG16727 1.36 1.05E-03 
WBGene00024012 Cbr-dod-23 CBG00648 1.89 1.06E-03 
WBGene00035690  CBG15413 1.33 1.24E-03 
WBGene00089048  CBG27634 1.19 1.29E-03 
WBGene00040031  CBG21186 -1.19 1.38E-03 
WBGene00087810  CBG26396 1.40 1.69E-03 
WBGene00024644  CBG01397 1.26 1.75E-03 
WBGene00042393  CBG24231 1.13 1.90E-03 
WBGene00032390 Cbr-tsp-10 CBG11232 -1.65 1.97E-03 
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WBGene00038211 Cbr-fil-2 CBG18901 1.70 2.02E-03 
WBGene00024424  CBG01149 -1.19 2.04E-03 
WBGene00031699  CBG10283 2.79 2.12E-03 
WBGene00026980  CBG04269 1.38 2.28E-03 
WBGene00030996 Cbr-zip-5 CBG09406 1.20 2.28E-03 
WBGene00034760  CBG14183 -1.56 2.34E-03 
WBGene00029305  CBG07164 2.32 2.36E-03 
WBGene00031014 Cbr-clec-41 CBG09432 1.08 2.36E-03 
WBGene00031133 Cbr-lys-1 CBG09572 1.19 2.36E-03 
WBGene00027938  CBG05498 1.09 2.39E-03 
WBGene00042154  CBG23917 1.13 2.73E-03 
WBGene00042557  CBG24449 1.27 2.99E-03 
WBGene00033962  CBG13153 1.14 3.11E-03 
WBGene00039297  CBG20274 3.43 3.11E-03 
WBGene00034396  CBG13659 -1.83 3.38E-03 
WBGene00028442 Cbr-lys-10 CBG06112 -1.19 3.39E-03 
WBGene00034314  CBG13564 1.20 3.76E-03 
WBGene00027936  CBG05496 1.17 4.42E-03 
WBGene00031840  CBG10453 -1.22 4.51E-03 
WBGene00034325  CBG13577 -2.30 4.65E-03 
WBGene00089049  CBG27635 2.38 4.65E-03 
WBGene00088644  CBG27230 2.07 5.33E-03 
WBGene00038267  CBG18975 1.19 5.74E-03 
WBGene00032554  CBG11440 1.41 5.84E-03 
WBGene00032734  CBG11640 1.74 6.09E-03 
WBGene00034204  CBG13437 1.30 6.12E-03 
WBGene00027240  CBG04601 -1.01 6.13E-03 
WBGene00023702  CBG00290 1.03 6.45E-03 
WBGene00034397  CBG13660 -1.70 6.65E-03 
WBGene00040550  CBG21872 1.73 6.65E-03 
WBGene00041518  CBG23101 1.38 6.65E-03 
WBGene00038677  CBG19468 0.92 7.75E-03 
WBGene00034814  CBG14250 1.53 8.40E-03 
WBGene00038302 Cbr-srh-30 CBG19015 -1.59 8.63E-03 
WBGene00032523 Cbr-aip-1 CBG11407 1.02 8.63E-03 
WBGene00023854  CBG00473 0.98 8.74E-03 
WBGene00027112 Cbr-fmo-2 CBG04445 -2.96 8.98E-03 
WBGene00088337  CBG26923 3.14 9.10E-03 
WBGene00038715  CBG19511 1.35 9.16E-03 
WBGene00031696  CBG10279 1.28 9.99E-03 
WBGene00089523  CBG28109 1.10 1.02E-02 
WBGene00089232  CBG27818 -1.15 1.03E-02 
WBGene00089257  CBG27843 -1.18 1.03E-02 
WBGene00026112  CBG03210 0.95 1.04E-02 
WBGene00024899  CBG01704 -2.81 1.07E-02 
WBGene00038689  CBG19480 1.74 1.11E-02 
WBGene00035681  CBG15402 1.10 1.12E-02 
WBGene00041721  CBG23351 -1.13 1.45E-02 
WBGene00025479  CBG02420 1.26 1.48E-02 
WBGene00029304  CBG07163 1.43 1.55E-02 
WBGene00028186  CBG05802 0.98 1.58E-02 
WBGene00034719 Cbr-clec-265 CBG14118 0.88 1.58E-02 
WBGene00036484 Cbr-odd-1 CBG16590 1.96 1.58E-02 
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WBGene00033785  CBG12921 -0.90 1.61E-02 
WBGene00031068  CBG09500 -0.90 1.69E-02 
WBGene00033160  CBG12168 1.54 1.75E-02 
WBGene00027937  CBG05497 0.90 1.77E-02 
WBGene00038243 Cbr-lec-10 CBG18946 0.97 1.77E-02 
WBGene00031839  CBG10452 -1.27 1.79E-02 
WBGene00032855  CBG11786 0.88 1.81E-02 
WBGene00031139  CBG09578 0.86 2.00E-02 
WBGene00027246  CBG04607 2.60 2.01E-02 
WBGene00031006  CBG09423 -1.20 2.11E-02 
WBGene00032190  CBG10961 1.49 2.19E-02 
WBGene00024847 Cbr-trpl-5 CBG01638 1.80 2.31E-02 
WBGene00042446 Cbr-srv-36 CBG24302 1.42 2.43E-02 
WBGene00042842  CBG24810 1.81 2.43E-02 
WBGene00042155  CBG23918 0.81 2.58E-02 
WBGene00042510  CBG24384 1.27 2.58E-02 
WBGene00028840  CBG06590 1.40 2.62E-02 
WBGene00038518  CBG19264 -0.85 2.62E-02 
WBGene00026258 Cbr-ech-9 CBG03388 1.40 2.65E-02 
WBGene00032570  CBG11458 -0.90 2.77E-02 
WBGene00031158 Cbr-ugt-33 CBG09597 -0.93 2.84E-02 
WBGene00042997  CBG25024 0.99 2.88E-02 
WBGene00024846 Cbr-trpl-2 CBG01637 1.10 2.94E-02 
WBGene00023858  CBG00478 1.06 3.12E-02 
WBGene00024530 Cbr-cyp-34A4 CBG01268 -1.59 3.18E-02 
WBGene00036233  CBG16219 -1.23 3.18E-02 
WBGene00035992 Cbr-cyp-37B1 CBG15879 -2.38 3.21E-02 
WBGene00042579  CBG24479 1.40 3.26E-02 
WBGene00028081 Cbr-ddo-1 CBG05678 -0.93 3.29E-02 
WBGene00034022  CBG13231 1.95 3.29E-02 
WBGene00037430  CBG17920 1.26 3.39E-02 
WBGene00086739  CBG25325 1.38 3.51E-02 
WBGene00028101  CBG05701 1.09 3.51E-02 
WBGene00037984 Cbr-acs-2 CBG18597 -1.19 3.55E-02 
WBGene00036291  CBG16316 -0.93 3.76E-02 
WBGene00030656  CBG08978 0.87 4.07E-02 
WBGene00040381 Cbr-him-6 CBG21676 1.91 4.07E-02 
WBGene00025722 Cbr-chil-11 CBG02717 1.49 4.11E-02 
WBGene00039441  CBG20465 -0.77 4.11E-02 
WBGene00040925  CBG22335 1.34 4.25E-02 
WBGene00038821  CBG19641 1.44 4.29E-02 
WBGene00041481  CBG23055 0.91 4.36E-02 
WBGene00041829  CBG23478 -1.59 4.36E-02 
WBGene00026151  CBG03259 1.26 4.51E-02 
WBGene00024292  CBG00992 3.14 4.61E-02 
WBGene00042363  CBG24195 1.09 4.63E-02 
WBGene00035196 Cbr-ifta-1 CBG14804 1.03 4.71E-02 
WBGene00034515  CBG13818 -1.13 4.71E-02 
WBGene00032104 Cbr-ilys-5 CBG10836 -0.87 4.96E-02 
 
Supplementary Table 2.5 Summary of Orsay virus DEGs in C. elegans that have C. 
briggsae orthologs DEGs by Santeuil virus infection. 
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C. elegans 
WBG 
name 
C. 
briggsae 
ortholog 
Sequen
ce 
Name 
Gene 
Nam
e 
Orsay [rde-1] 
log2 fold 
change 
Orsay [N2] 
log2 fold 
change 
Santeuil 
[JU1264] log2 
fold change 
N. parisii [N2] 
log2 fold 
change 
WBGene0
0006986 
WBGene
00087233 
Y75B8
A.35 
zip-1 1.35  1.37 0.83 
WBGene0
0007097 
WBGene
00031139 
B0024.
4 
 5.43  0.86  
WBGene0
0007132 
WBGene
00028845 
B0284.
2 
 6.27 3.82 7.86 5.08 
WBGene0
0007134 
WBGene
00028845 
B0284.
4 
 8.91 8.31 7.86 9.81 
WBGene0
0007153 
WBGene
00031014 
B0365.
6 
clec-
41 
2.73  1.08  
WBGene0
0007180 
WBGene
00026112 
B0457.
6 
 1.94  0.95  
WBGene0
0007297 
WBGene
00026507 
C04F1
2.1 
 2.83 1.56 1.25 1.58 
WBGene0
0007656 
WBGene
00028731 
C17H1.
3 
 7.88 5.86 3.86 7.59 
WBGene0
0007657 
WBGene
00028845 
C17H1.
4 
 9.95 5.53 7.86 7.09 
WBGene0
0007659 
WBGene
00028845 
C17H1.
6 
 9.56 6.72 7.86 7.94 
WBGene0
0007660 
WBGene
00028845 
C17H1.
7 
 6.51 4.09 7.86 5.09 
WBGene0
0007932 
WBGene
00030996 
C34D1.
5 
zip-5 2.95  1.20  
WBGene0
0008301 
WBGene
00041841 
C54D1
0.7 
dct-3 6.03 4.14 5.61 6.11 
WBGene0
0008302 
WBGene
00041843 
C54D1
0.8 
 5.53 3.61 1.77 5.78 
WBGene0
0008850 
WBGene
00031046 
F15B9.
6 
 3.25  2.14 1.97 
WBGene0
0008872 
WBGene
00031174 
F15H1
0.5 
 7.18 3.94 4.46 7.20 
WBGene0
0009061 
WBGene
00028731 
F22G1
2.1 
 8.35 6.18 3.86 6.82 
WBGene0
0009898 
WBGene
00024012 
F49E12
.2 
dod-
23 
5.46 2.67 1.89 3.70 
WBGene0
0010004 
WBGene
00088337 
F53H2.
1 
 2.51  3.14 4.58 
WBGene0
0010764 
WBGene
00024292 
K10H1
0.9 
 7.52  3.14  
WBGene0
0010977 
WBGene
00027239 
R02D5.
3 
 1.86  1.77  
WBGene0
0011979 
WBGene
00026151 
T24B8.
5 
 3.18  1.26 2.54 
WBGene0
0012091 
WBGene
00041842 
T27E7.
6 
 9.80 6.73 7.17 8.91 
WBGene0
0012101 
WBGene
00041674 
T27F2.
4 
zip-
10 
4.33  3.00  
WBGene0
0012381 
WBGene
00028943 
Y2H9A
.4 
 2.40 1.20 1.91 2.18 
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WBGene0
0012399 
WBGene
00032650 
Y6E2A
.5 
 3.81 2.18 3.49 3.66 
WBGene0
0013073 
WBGene
00033785 
Y51A2
D.4 
hmit-
1.1 
-1.42  -0.90  
WBGene0
0013294 
WBGene
00031866 
Y57G1
1B.1 
 7.01 2.96 5.91 4.47 
WBGene0
0015223 
WBGene
00088337 
B0507.
6 
 5.07 2.74 3.14 4.60 
WBGene0
0015224 
WBGene
00037933 
B0507.
7 
 4.72 3.22 7.17 5.21 
WBGene0
0015225 
WBGene
00037934 
B0507.
8 
 9.07 6.45 9.06 7.72 
WBGene0
0015226 
WBGene
00037935 
B0507.
9 
 5.38  8.33 2.57 
WBGene0
0015227 
WBGene
00037931 
B0507.
10 
 8.08 5.80 4.90 7.38 
WBGene0
0015537 
WBGene
00087767 
C06E4.
8 
 4.05  1.40 2.30 
WBGene0
0016281 
WBGene
00028731 
C31B8.
4 
 5.24 3.11 3.86 3.52 
WBGene0
0016783 
WBGene
00024645 
C49G7.
5 
irg-2 2.89  1.68  
WBGene0
0016788 
WBGene
00024645 
C49G7.
10 
 2.69  1.68  
WBGene0
0017445 
WBGene
00032171 
F14B8.
2 
sid-5 1.53  1.47  
WBGene0
0017466 
WBGene
00030434 
F14F9.
3 
  1.98 1.69  
WBGene0
0017467 
WBGene
00030434 
F14F9.
4 
 2.08  1.69  
WBGene0
0018345 
WBGene
00028205 
F42C5.
3 
 9.51 6.49 4.72 7.75 
WBGene0
0018643 
WBGene
00042151 
F49F1.
1 
drd-
50 
3.25  2.69  
WBGene0
0019564 
WBGene
00024644 
K09D9
.1 
 2.49  1.26  
WBGene0
0020227 
WBGene
00026106 
T05A8.
1 
 9.66 3.70 6.34 5.50 
WBGene0
0020760 
WBGene
00042363 
T24C4.
4 
 2.72  1.09  
WBGene0
0020774 
WBGene
00026106 
T24E1
2.5 
 3.01 1.17 6.34 2.03 
WBGene0
0021654 
WBGene
00026106 
Y47G7
B.2 
 2.39  6.34  
WBGene0
0021977 
WBGene
00030434 
Y58A7
A.3 
 1.68  1.69  
WBGene0
0021978 
WBGene
00030434 
Y58A7
A.4 
 2.80  1.69  
WBGene0
0021979 
WBGene
00030420 
Y58A7
A.5 
 4.68  2.90  
WBGene0
0022547 
WBGene
00037926 
ZC196.
3 
 6.20 3.00 2.55 3.47 
WBGene0
0022673 
WBGene
00025479 
ZK177.
8 
  0.87 1.26  
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WBGene0
0044013 
WBGene
00031174 
F15H1
0.9 
 9.07 4.87 4.46 8.76 
WBGene0
0044014 
WBGene
00031174 
F15H1
0.10 
 11.30 8.09 4.46 10.85 
WBGene0
0044427 
WBGene
00086653 
F56A6.
5 
 9.10  5.91 6.80 
WBGene0
0044787 
WBGene
00041840 
C54D1
0.12 
 4.42 2.37 5.47 4.45 
WBGene0
0045475 
WBGene
00042683 
T07A5.
7 
 5.07  2.81 3.03 
WBGene0
0138721 
WBGene
00041840 
C54D1
0.14 
 5.88 3.92 5.47 6.20 
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Abstract 
  
C. elegans is an excellent model organism with a variety of genetic tools available to 
investigate host-pathogen interactions. With the recent discovery of Orsay virus, the first virus 
that naturally infects C. elegans, we are now able to examine how Orsay virus interacts with the 
host. I have found that when Orsay virus infected the reference strain N2, there were high 
variations among the replications from the same experiment. This result was consistent with both 
animals grown on solid medium or in a liquid medium. In contrast, the hyper-permissive strain 
rde-1 with compromised RNA interference (RNAi) pathway had less variation and were 
significantly higher in viral RNA than that of N2.  
An important genetic tool for C. elegans is the targeted silencing of mRNA with RNAi 
by feeding the worms homologous double-stranded RNA of that gene. I have discovered that the 
feeding RNAi may compete with antiviral RNAi as targeting GFP with RNAi in a GFP-
expressing strain had increased amount of Orsay virus RNA. With these better understanding of 
the Orsay virus infection characteristics in C. elegans, we can now determine the optimal 
experimental conditions based on the specific hypotheses we want to test. 
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Introduction 
 
Orsay virus, the first virus that can naturally infect C. elegans was recently described [1]. 
Orsay virus is a non-enveloped virus that has a positive sense bipartite RNA genome, and it is 
most closely related to Nodaviridae. With this discovery, we can now interrogate the C. elegans 
– Orsay virus model system to understand the host-virus interactions better. There are currently 
two known cellular pathways utilized by C. elegans to antagonize Orsay virus replication. One 
host pathway is the antiviral RNA interference (RNAi) that directly restricts Orsay virus 
replication [1,2]. The other host pathway is the ubiquitin-proteasome pathway where the Skp1 - 
Cul1- F-box protein (SCF) ligase is essential for restricting Orsay virus [3]. However, many of 
the host factors that are involved in other stages of the virus lifecycle such as entry, translation of 
viral protein, assembly of virus particles and release/egress of the virus remain unknown in C. 
elegans.  
Orsay virus infection in C. elegans reference strain N2 neither reduces the lifespan of the 
host nor causes any obvious physiological change [1]. The virus hyper-permissive strains where 
the RNAi function was compromised, also did not have shortened lifespan, but disturbance of the 
worm intestinal cells and increased Orsay virus RNA were observed [1,2,4]. The limited 
physiological change in the N2 strain and no lethality by the Orsay virus infection means that the 
measurement of Orsay virus replication will largely depend on molecular tools. Also, the ability 
to measure the amount of virus replication for each stage of the virus lifecycle can help dissect 
the role of a specific host factor. To that end, the Wang lab had developed assays to measure 
Orsay virus RNA with real-time quantitative reverse transcription PCR (qRT-PCR) [1], Orsay 
virus proteins with immunofluorescence assay [5], and Orsay virus titer with an end point 
dilution assay [6].  
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The model organism C. elegans has many useful genetic tools to facilitate research in the 
model organism. Some of the tools included a large collection of knockout animals [7], the 
ability to knockdown genes by feeding worms with bacteria that expressed dsRNA of the gene of 
interest [8], and CRISPR/Cas9 system to knockout individual genes [9]. However, before we can 
utilize the full suite of genetic tools available to investigate the interaction between C. elegans 
and Orsay virus, it is essential to characterize the infection process better and determine the 
limitation of the developed assays. It is of particular importance to understand how the controls 
behave to determine the optimal infection conditions and interpret the experimental results 
properly. Here, I present a systematic approach to characterize Orsay virus infection in C. 
elegans with the reference N2 strain and RNAi feeding.  
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Results 
 
Virus replication is variable in N2 strain on NGM plates 
N2 reference strain is the foundation of most of the genetic tools developed for C. 
elegans. To better understand the amount of Orsay virus that is replicating in the C. elegans 
hosts, we infected the worms at two multiplicity of infection (MOI) of 10 and 0.1 and different 
length of infection time; two and three days. In addition to the N2 reference strain, I used rde-1, 
an RNAi-deficient strain that is hyper-permissive for Orsay virus infection as a positive control 
to determine the upper limits of virus replication and an input control to determine how much 
virus were introduced from the initial virus dose. I first infected both strains with a relatively 
high MOI of 10 for two days. The total RNA of these infected worms and the input controls were 
extracted, and the Orsay virus RNA were measured by qRT-PCR. The N2 infected worms have 
over 2-log higher geometric mean of Orsay RNA compared to input, indicating successful 
infection, and the hyper-permissive strain rde-1 have approximately 5-log higher geometric 
mean of Orsay RNA (Figure 3.1). This observation was consistent with our expectation that the 
RNAi-deficient strain would have higher Orsay virus replication. One interesting result was the 
high variation between replications in N2 as the range between the maximum value to the 
minimum value for Orsay RNA in the N2 strain span approximately 3-log (Figure 3.1). The next 
condition tested was at a lower MOI of 0.1 and the same 2-day infection time. The amount of 
input virus measured was lower which is consistent with the lower amount of input virus (Figure 
3.1). Orsay RNA in N2 strain was 2-log higher compared to input indicating that infection of 
Orsay virus was successful. However, the variation of Orsay RNA among N2 replicates was now 
larger as the range of Orsay RNA in N2 now spans almost 7-log. Some of the samples had a 
lower Orsay RNA that were comparable to the input suggesting that Orsay virus infection was 
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not successful in these samples. In contrast, the rde-1 mutant was approximately 6-log higher in 
Orsay RNA than input and had a low variation. The last condition tested was at an MOI of 10 
and 3-day infection. The N2 strain had comparable geometric means between 2-day and 3-day 
infection, and the 3-day infection time did not reduce the variation between replications. The 
rde-1 mutant had approximately 6-log higher Orsay RNA than input and a low variation, overall 
comparable to 2-day infection. The lack of difference between 2-day and 3-day infection at MOI 
of 10 suggest that we may have observed the peak viral replication capacity of Orsay virus in 
both N2 and rde-1.  
 
Figure 3.1: Orsay virus replication in N2 and rde-1 on solid medium/NGM plate. 500 N2 or 
rde-1 worms were infected by Orsay virus (MOI 10 or 0.1) for 2 or 3 days. The amount of Orsay 
virus replication was measured by qRT-PCR and normalized to cdc-42. The individual value, the 
geometric mean, and the 95% CI are shown. 
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Liquid infection did not reduce variation of infection in N2 strain 
The high variation of Orsay virus infection in N2 on NGM plates was less than ideal. To 
make N2 a more reliable control with reduced variations, I investigated if an alternative culturing 
condition, liquid culture, could be a better option. The liquid culture had a potential advantage 
over solid medium in that the liquid culturing condition was more homogenous. This advantage 
can potentially enable more consistent infections. I tested a stable liquid infection condition 
where the input virus was incubated with worms for the entire duration of the infection. For this 
condition, N2 and rde-1 worms were cultured in liquid culture infected with Orsay virus at MOI 
of 50, 5, and 0.5 for three days. For the MOI 50 and 5 conditions, infection was successful as 
both N2 and rde-1 had increased Orsay RNA compared to input (Figure 3.2). However, the 
lowest MOI condition of 0.5 had limited increase of Orsay RNA as the geometric means did not 
change in both N2 and rde-1 worms when compared to input (Figure 3.2). Some samples in the 
MOI 0.5 condition were 2-log higher than the input, however, most of the replicates did not. This 
data suggests that MOI 0.5 is likely too low to consistently achieve infection in liquid culture. 
For the MOI 50 condition, N2 increased less than 1-fold compared to input and rde-1 increased 
less than 2-log. These data suggest that the input virus might mask the real virus replication in 
infected worms (Figure 3.2). For the MOI 5 condition, the N2 median Orsay virus increased by 
more than 1-log where rde-1 increased by more than 2-log (Figure 2.2B). However, the variation 
in N2 is high and spanned over 2-log, and multiple samples have Orsay RNA amount close to 
either the input or infected rde-1. These data suggest liquid culture infection did not reduce the 
variation of Orsay virus replication in N2 observed in solid medium culture. 
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Figure 3.2: Orsay virus replication in N2 and rde-1 in a liquid medium. 100 N2 or rde-1 
worms were infected by Orsay virus (MOI 50, 5, or 0.5) for 3 days in liquid culture. The amount 
of Orsay virus replication was measured by qRT-PCR. The individual value, the geometric 
mean, and the 95% CI are shown. 
 
The process of feeding RNAi may compete with antiviral RNAi 
Orsay virus replication is strongly influenced by the antiviral RNAi pathway [1], and 
both the antiviral RNAi pathway and exo-RNAi pathway have shared components [10]. It is, 
therefore, possible that both processes might compete and results in reduced RNAi efficiency in 
one or the other. To test this hypothesis, we used a previously described transcriptional GFP 
reporter strain that was induced by Orsay virus infection [3]. This strain carried an integrated 
transgene comprised of the promoter of C17H1.6, a gene strongly induced by Orsay infection, 
fused to GFP. The GFP expressed in the reporter worms provided a transcript target for feeding 
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RNAi that was not related to the host-virus interaction. This GFP RNAi control would allow the 
activity of exo-RNAi to occur in the GFP-expressing worms. The amount of Orsay virus RNA in 
this control can help determine if the exo-RNAi influenced the replication of Orsay virus. In 
addition to the GFP RNAi, two addition controls were used.  The first bacteria clone was an 
empty vector control that expresses a short dsRNA (~180bp) that does not have sequence 
homology to worm genome as a control for the bacteria and plasmid. The second target is rde-1, 
which is a member of both exo-RNAi and antiviral RNAi. Targeting of rde-1 would serve as a 
control for reduced RNAi capacity. Synchronized worms were fed RNAi clones expressing 
dsRNA of the controls for two days and infected at an MOI of 10 or 0.1 for another two days. 
When RNAi knocked down worms were infected with Orsay virus at MOI of 10; the rde-1 
targeted samples had approximately 1-log more Orsay virus RNA compared to empty vector 
(Figure 3.3) and statistically different. This observation suggests that the rde-1 RNAi was 
successful although the degree of difference was not as large when compared to knockout 
mutants (Figure 3.1). For the GFP RNAi worms, the observed Orsay virus RNA were 
statistically higher than empty vector and statistically lower than rde-1 (Figure 3.3). This 
suggested that the GFP RNAi did compete with antiviral RNA causing the Orsay virus 
replication to increase. When the worms were infected at a lower MOI of 0.1, the overall amount 
of Orsay virus RNA compared to MOI 10 were lower in all three controls, and the difference 
between rde-1 and empty vector is larger at approximately 3-log (Figure 3.3). However, the 
variation between replications in the same control also increased from within 2-log for MOI 10 
to more than 4-log for MOI 0.1. The GFP target control at this condition was the most varied at 
more than 5-log. All these data suggested that feeding RNAi to host genes may change the 
overall Orsay RNA replication even if it is not antiviral-related.  
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Figure 3.3: RNAi feeding of non-antiviral gene resulted in increased virus replication at 
MOI of 10. 500 synchronized N2/jyIs8 were fed with induced bacterial clone expressing dsRNA 
of the targeted genes for 2 days. Worms were then infected with Orsay virus at MOI of 10 or 0.1 
for 2 days. The amount of Orsay virus replication was measured by qRT-PCR. The bar 
represents the geometric mean of the measured values. The individual value, the geometric 
mean, and the 95% CI are shown. Statistical significance was assessed using Kruskal-Wallis test 
with Benjamini–Hochberg procedure for all pairwise comparison for each MOI. *P<0.05, 
***P<0.001, n.s. - not significant.  
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Discussion and Conclusion 
 
Characterizing how Orsay virus replicates in C. elegans is an important precursor to 
studying host-virus interactions. It will help us better understand the biology of Orsay virus and 
allow us to determine the suitable conditions to assay the effect of host genes to virus infections. 
One interesting finding was that the laboratory reference strain N2 was highly variable, 
especially at the relatively low MOI conditions (MOI < 1). This result contrasts with the low 
variation in the hyper-permissive strain rde-1. In the N2 strain, 2-day or 3-day infection with 
MOI 10 did not have a significant difference as the median is similar between the two and both 
have more than 3-log variation between the replicates. The similar amount of Orsay virus RNA 
between the 2-day and 3-day infection suggest that it may reach the peak capacity of infection 
for N2 at this stage. The high variation in N2 may indeed indicate that the host-virus interaction 
relies on some stochastic process that is yet to be defined. 
One possible approach to minimize variation changes the infection environment from 
solid medium to liquid medium. The homogeneous environment of liquid infection could 
potentially reduce variation. However, we found that the liquid culture infection did not reduce 
variation in the similar MOI. At the MOI 50 condition, we did found that the variation was 
reduced, but that was most likely because the input virus has provided a high baseline of Orsay 
virus RNA and masked the potential variations in N2.  
RNAi feeding to knock down host gene transcript from external dsRNA (exo-RNAi) is 
an important genetic tool for the model organism C. elegans. Knocking down host genes with 
RNAi is efficient, however, can have variable efficiency depending on the specific target. 
Another limitation is the reduced efficiency when targeting multiple genes for knockdown with 
RNAi [11]. While the precise reason is not entirely determined, a recent study suggests that 
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multiple RNAi pathways compete for finite shared components [12]. We found that feeding GFP 
RNAi alone has increased Orsay virus RNA when compared to empty vector control. Therefore, 
caution is required when interpreting results of Orsay virus replication from RNAi knockdown 
experiments. Also, the GFP is a better control for future RNAi experiments as it controlled the 
effect of exo-RNAi. Additionally, low MOI conditions were not advised as the potential 
competition between host gene RNAi and anti-viral RNAi produced highly variable results. 
However, if any of the genes have a significant phenotype, the RNAi should be able to reveal 
strong candidate host genes that interact with Orsay virus replication. 
Together, these results have better defined the characteristics of Orsay virus replication in 
C. elegans. These finding will also help guide the optimal selection of infection conditions to 
efficiently screen for genes that may have a role in the host-virus interactions. 
 
Materials and Methods 
 
Strains 
C. elegans strains N2, and rde-1 (WM27) along with C. briggsae strain AF16 were obtained 
from the Caenorhabditis Genetics Center (CGC). The GFP reporter strain ERT54 jyIs8 
[pC17H1.6::GFP; pmyo-2::mCherry] was kindly provided by Emily Troemel [3].  
 
Infectious virus filtrate preparation 
Orsay virus and Santeuil virus were propagated as previously described in Chapter 1.  
 
Worm infection on solid medium 
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Uninfected C. elegans (N2 and rde-1) and uninfected C. briggsae (AF16) were synchronized by 
standard bleach treatment. 500 embryos were seeded per well into 6-well NGM plates containing 
20-30 μl of OP50 food and maintained at 20°C. 16 hours after bleaching; worms were inoculated 
by adding 20 μl of Orsay virus of starting at 2.5 x 105 TCID50 /ml for an MOI of ~10 directly 
over the bacterial lawn. Lower MOI infection conditions were obtained by additional 10-fold 
dilution of the starting Orsay virus stock. After two days or three days post-infection, animals 
were rinsed off from the wells with 1 ml M9 buffer, the supernatant was removed after 
centrifugation, and 350 ul Trizol were added to the samples. 
 
Worm infection in liquid medium 
Uninfected C. elegans (N2 and rde-1) were synchronized by standard bleach treatment and 
arrested at the L1 stage. 100 worms in 20 μl S-media were added to each well on a 96-well plate 
along with 10 μl of 50x concentrated OP50 and 20 ul of Orsay virus of starting at 2.5 x 105 
TCID50 /ml for an MOI of 50. Lower MOI infection conditions were obtained by additional 10-
fold dilution of the starting Orsay virus stock. After 2 or 3 day post infection, all contents in the 
well were collected into 350 μl Trizol. 
 
RNAi feeding knockdown infection on solid medium 
RNAi feeding was used for gene knockdown as described [8].  E. coli strain HT115 
carrying double strand RNA expression cassettes for genes of interest were induced using 
established conditions and were then seeded into 6-well NGM plates. Empty vector, rde-1 RNAi 
clones were from the Ahringer RNAi library [13]. 500 arrested GFP reporter animals were 
seeded into each well of a 6-well plate. After two days of RNAi feeding, Orsay virus was added 
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to the plates as described with solid medium infection. After 2-day infection, the infected C. 
elegans animals were collected as described with solid medium infection. 
 
Measuring Orsay virus RNA by real-time quantitative one-step RT-PCR (qRT-PCR 
Infected worm samples in Trizol were vortexed for 10 minutes at room temperature and 
centrifuged at 15,000g for 5 minutes. The Trizol supernatants were extracted with Direct-zol 
RNA miniprep kit (Zymo) and were eluted into 60 μl water. The extracted samples were diluted 
1:100 and 5 μl of the diluted RNA were used for one-step real-time RT-PCR (TaqMan® Fast 
Virus 1-Step Master Mix, Thermo-fisher) on a ViiA7 real-time PCR system (Applied Biosystem) 
following the manufacturer’s protocol. The copy number for each sample was calculated from a 
standard curve and was normalized to an internal control cdc-42 gene. 
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Chapter 4: Systematic screening of genes that 
impacted Orsay virus replication from the 
evolutionarily conserved virus response genes 
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Abstract 
 C. elegans is an excellent model organism to investigate the host-virus interaction with 
the recent discovery of its naturally infecting Orsay virus. To determine if the 58 evolutionarily 
conserved differentially expressed genes (DEGs) from Chapter 2 impacted Orsay virus 
replication either positively or negatively, I perturbed the expression these candidate genes with 
overexpression, RNAi knockdown, readily available knockout mutants, and new knockout 
mutants generated by CRISPR/Cas9. After measuring the amount of Orsay virus replication 
phenotype by quantitative real-time PCR and end-point dilutions assays, I have found 1) 
Overexpression of some viral DEGs may have a protective effect in Orsay virus infection. 2) 
RNAi knockdown of all these 58 DEGs did not identify any of these genes as functional in   
host-virus interaction. 3) T27E7.6, a gene in the C17H1 gene family may play an antiviral role. 
4) zip-10, a nematode bZIP transcription factor, may be a proviral gene that facilitates Orsay 
virus infection. Both T27E7.6 and zip-10 were not known to be associated with virus replication, 
suggesting novel host-virus interactions may have been identified.  
 
Introduction 
With the recent discovery of its naturally infecting Orsay virus, C. elegans has became an 
excellent model organism to investigate the host-virus interactions [1]. Orsay virus is a non-
enveloped virus that has a positive sense bipartite RNA genome, and it is most closely related to 
Nodaviridae. With this discovery, we can now interrogate the C. elegans – Orsay virus model 
system to better understand the host-virus interactions. There are currently two known cellular 
pathways utilized by C. elegans to antagonize Orsay virus replication. One host pathway is the 
antiviral RNA interference (RNAi) that directly restricts Orsay virus replication [1,2]. The other 
host pathway is the ubiquitin-proteasome pathway where the Skp1 - Cul1- F-box protein (SCF) 
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ligase is important for restricting Orsay virus [3]. However, many of the host factors that are 
involved in other stages of the virus life cycle such as entry, translation of viral protein, assembly 
of virus particles and egress of the virus remain unknown in C. elegans.  
In C. elegans genetics, there are two broad categories of approaches to identify genes in 
the host-virus interactions. One of the approach is the forward genetic screen that identifies 
causal mutation from chemical mutagenized animals with phenotype related to Orsay virus 
replication [4]. The other approach is a reverse genetic screen that investigates a specific set of 
genes (whole genome or a biological relevant set) and its relationship with Orsay virus 
replication [5].  The specific approach taken for the current study was a reverse genetic screens 
of likely host-virus interaction genes. There are multiple ways to select a biological relevant set 
of genes in the host-virus interaction, including genes under positive selection pressure [5], 
proteins that directly interacts with virus [5], and genes that responded to virus infection.   
The prime candidates for a genetic screen were the differentially expressed genes (DEGs) 
upon virus infection [6]. More specifically, the evolutionarily conserved DEGs between C. 
elegans and C. briggsae, a close relative pair diverged ~18 million years ago and shared 60% of 
the protein coding genes, were the most interesting set. The overlapping response to its own 
unique virus in two related species provides a unique set of genes that represent an evolutionarily 
conserved process that could interact with virus infection.  
The model organism C. elegans has many useful genetic tools to facilitate research in the 
model organism. Some of the tools included a large collection of knockout animals [8], the 
ability to knockdown genes by feeding worms with bacteria that expressed dsRNA of the gene of 
interest [9], and the CRISPR/Cas9 system to knockout individual genes [10]. Combined with the 
available assays to measure Orsay virus RNA with real-time quantitative reverse transcription 
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PCR (qRT-PCR) [1], Orsay virus proteins with immunofluorescence assay [7], and Orsay virus 
titer with an end point dilution assay [6]. We can fully interrogate host genes that interacts with 
Orsay virus. Here, I present a systematic screening to identify host genes that influenced Orsay 
virus infection in C. elegans. 
 
Results 
 
Overexpression of virus-induced genes have reduced Orsay virus replication 
To determine if differentially expressed genes upon Orsay virus infection were involved 
in host-virus interactions, I tested two mutants that constitutively overexpressed some of these 
genes. These two strains, JY1 and JY3, both contain mutation to C29F9.1, constitutively 
overexpressed the three virus induced genes C17H1.6, F26F2.1, and F26F2.4 by over 100-fold 
(Personal communication with Emily Troemel). I infected the worms with Orsay virus and 
measureed the amount of Orsay virus RNA by quantitative real-time reverse-transition PCR 
(qRT-PCR). When worms were infected at a high MOI of 10, there was no difference between 
the virus DEGs overexpression strain JY1 and JY3 to their control N2. However, at a lower MOI 
of 0.1, the two overexpression strains had lower Orsay virus RNA compared to N2. The two 
independent strains had similar results in both MOI conditions. These results suggested that the 
C29F2.1 regulated genes that include several virus DEGs may have antiviral properties.  
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Figure 4.1. Virus DEGs overexpression strains JY1 and JY3 have lower Orsay virus 
replication at low MOI condition. Mutants JY1 and JY3 which overexpressed multiple virus-
induced genes were infected with Orsay virus. The amount of Orsay virus RNA was measured 
by qRT-PCR. The three control conditions used were the input virus, infection of N2 and rde-1 
strains. The individual value, the geometric mean, and the 95% CI are shown. Statistical 
significance was assessed using Kruskal-Wallis test with Dunn’s post hoc test against N2. 
*P<0.05, ***P<0.0005, n.s. - not significant.  
 
Knockdown of evolutionarily conserved DEGs by RNAi did not influence Orsay virus 
replication  
To screen for genes that were involved in host-virus interactions from the 58 
evolutionarily conserved DEGs, I knocked down these genes individually using RNAi feeding 
[9,11,12]. I conducted the RNAi knockdown experiment in two different genetic backgrounds. 
The first was the reference strain with a GFP reporter and the second was a drh-1 mutant which 
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is competent for feeding RNAi but not anti-viral RNAi [14]. Conducting RNAi in the GFP 
reporter strain allowed us to use GFP RNAi as a proper control for potential competition 
between the exo-RNAi and antiviral RNAi. The use of drh-1 strain was to determine if there 
were genes that act independently of the antiviral RNAi. 
I first fed the GFP reporter strain with the RNAi clones for three days and subsequently 
infected the animals with Orsay virus at an MOI of 10 for another two days. When compared to 
GFP control, no RNAi knockdown contributed to a difference in Orsay virus RNA amount 
(Figure 4.2A). The positive control RNAi targeting rde-1 was statistically significantly higher 
than the GFP control, however, the difference between the geometric means were less than 1-log. 
I next determined if any of the 58 evolutionarily conserved DEGs interacts with Orsay virus 
independently of the antiviral RNAi pathway.  I knocked down the DEGs with feeding RNAi in 
drh-1 animals for three days and infected them with Orsay virus at an MOI of 10 for two days. I 
have found that RNAi knockdown of the DEGs did not change Orsay virus RNA whem 
compared to drh-1 feeding control. Given the limitation of RNAi knockdown experiment, it is 
possible that some these genes may still participate in the host-virus interaction. More 
experiments are needed to determine if any of these 58 DEGs were indeed involved in host-virus 
interactions. 
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Figure 4.2. RNAi knockdown of the 58 evolutionarily conserved DEGs individually did not 
change the Orsay virus RNA amount.  The 58 evolutionarily conserved DEGs were 
individually knocked down by feeding RNAi for three days. Knocked down animals were 
infected with Orsay virus at MOI 10 for two days, and the amount of Orsay virus RNA was 
measured by qRT-PCR. A) RNAi feeding in N2 GFP reporter animals. Four controls were used 
including the empty vector, GFP, rde-1 and sid-3 (a proviral gene). Statistical significance was 
assessed using Kruskal-Wallis test with Dunn’s post hoc test against Control (GFP). B) RNAi 
feeding in drh-1 animals. Four controls were used including the empty vector, drh-1, rde-1, and 
sid-3. Statistical significance was assessed using Kruskal-Wallis test with Dunn’s post hoc test 
against Control (drh-1). The individual values, the geometric mean, and the 95% CI are shown. 
The order of genes presented was sorted by geometric means.  
 
The C17H1 gene family member T27E7.6 may be an antiviral gene 
From the analysis of virus infection DEGs, we identified an interesting gene family, the 
C17H1 gene family [6]. The C17H1 gene family was highly represented in the total list of C. 
elegans DEGs (25/320) and was also the most represented gene family in the evolutionarily 
conserved response DEGs (14/58). Multiple C17H1 gene family members had been tested by 
RNAi knockdown in the previous described RNAi knockdown experiments, and no genes were 
differentially expressed.  
To determine if any members of the C17H1 gene family were involved in Orsay virus 
replication, the best approach was to conduct the Orsay virus infection experiments in knockout 
mutants. Compared to RNAi knockdown, we can observe phenotype with a lower magnitude in 
the knockout mutants, and negative results will be more conclusive. While there were no mutant 
strains available that targeted C17H1 gene family members from the Caenorhabditis Genetics 
Center (CGC), there were five strains that contain high-impact mutations such as premature stop 
codon and splicing-editing dysfunction from the collection of Million Mutation Project [8]. We 
conducted the Orsay virus infection assay on these five strains and measured the Orsay virus 
RNA amount by qRT-PCR. We found the strain that contains T27E7.6 mutation had a 
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significantly increased Orsay virus RNA compared to N2 control (Figure 4.3). For the remaining 
four strains, the strain with the C54D10.8 mutation had lower Orsay virus RNA, but none of the 
four strains were statistically different from the N2. When these strains were infected at a lower 
MOI of 0.1, similar phenotype was observed, but none of these five strains were statistically 
different from N2 (Supplementary Figure 4.1). The mutant strain VC40577 that has T27E7.6 
mutation also had other mutations. One feature of the mutants from the Million Mutation Project 
is that there are multiple mutations in each strain [8]. Upon consulting the genomic sequencing 
results available for VC40577, we found there were three high-impact mutations including 
T27E7.6 and 87 missense mutations in protein coding genes. None of the mutated genes in the 
VC40755 strain were in the exo-RNAi pathway (Supplemental Table 4.2). Additionally, RNAi 
knockdown of dpy-3 in the VC40577 strain resulted in an animal with strong dumpy phenotype 
(data not shown) suggesting that the exo-RNAi pathway was intact. All these results indicate that 
T27E7.6, a member of the C17H1 gene family may be antiviral.  
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Figure 4.3. The screening of C17H1 gene family member mutants for Orsay virus 
replication. Mutants containing C17H1 gene family members were infected with Orsay virus at 
an MOI of 10 for two days. The Orsay virus RNA was measured by qRT-PCR. The three control 
conditions used were the input virus, infection of N2 and rde-1 strains. The individual value, the 
geometric mean, and the 95% CI are shown. Statistical significance was assessed using Kruskal-
Wallis test with Dunn’s post hoc test against N2. *P < 0.05.   
 
The C17H1 locus of the C17H1 gene family was not part of the host-virus interaction 
To further investigate if other members of the C17H1 gene family plays a role in the 
host-virus interactions, I generated a strain that knocked out the entire C17H1 locus with 
CRISPR/Cas9 system [10,15]. The mutant strain WUM6 has a deletion that spanned 35kb from 
C17H1.3 to C17H1.7 that includes 11 of the 25 upregulated C17H1 gene family and 4 of the 58 
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evolutionarily conserved DEGs. I then tested the Orsay virus replication phenotype on WUM6 
and found that Orsay virus RNA was not different to N2 (Figure 4.4). This observation was true 
in both MOI of 10 and MOI of 0.1 conditions. I next crossed the WUM6 with rde-1 to produce 
WUM6;rde-1 to determine if the C17H1 locus genes act independently of RNAi. We found that 
there was no difference between the rde-1 control and the WUM6;rde-1 strain (Figure 4.5A). 
One possibility was that the C17H1 locus genes might act downstream of replication and 
measure only Orsay virus RNA may not reflect that effect. I measured the Orsay virus titer in 
these samples with an end-point dilution assay that was similar to TCID50.  I found that the 
C17H1 locus alone did not influence the production of infectious Orsay virus (Figure 4.5B). 
These results suggest that the C17H1 locus genes alone were not involved in the host-virus 
interaction.  
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Figure 4.4. The C17H1 locus deletion mutant WUM6 did not have altered Orsay virus RNA 
amount. The WUM6 mutant contains a deletion to the C17H1 locus knocking out 11 of 25 
upregulated C17H1 gene family members. WUM6 was infected with Orsay virus with an MOI 
of 10 and 0.1 and for two days. The Orsay virus RNA was measured by qRT-PCR. The three 
control conditions used were the input virus, infection of N2 and rde-1 strains. The individual 
value, the geometric mean, and the 95% CI are shown. Statistical significance was assessed 
using Mann–Whitney U test against N2. n.s. not significant.  
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Figure 4.5. The C17H1 locus alone did not participate in the host-virus interactions. The 
WUM6 mutant were crossed into an antiviral RNAi defective strain rde-1. WUM6 and 
WUM6;rde-1was infected with Orsay virus with an MOI of 10 for three days. A) The amount of 
Orsay virus RNA was measured by qRT-PCR. B) The amount of infectious Orsay virus was 
titered with an end-point dilution assay that was similar to TCID50. The three control conditions 
used were the input virus, infection of N2 and rde-1 strains. The individual value, the geometric 
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mean, and the 95% CI are shown. Statistical significance was assessed using Mann–Whitney U 
test against N2. n.s. not significant.  
 
Two genes from the evolutionarily conserved DEGs, zip-1 and zip-10 may influence Orsay 
virus infection 
From the 58 conserved DEGs, there were 20 strains were available from the million 
mutation project that had high-impact mutations such as premature stop codon, frameshift, and 
splicing defects [8].  Additionally, seven genes that have knockout mutants were available from 
Caenorhabditis Genetics Center (CGC). To determine whether any of these mutants were 
involved in host-virus interaction, I have measured the Orsay virus replication phenotype of 
these mutants.  
First, I tested the 20 mutants from the Million Mutation Project. After the Orsay virus 
infection assay, I found that the mutant strain VC20199 that have zip-1 mutation, a gene that 
belonged to the bZIP transcription factor family, had statistically higher amount of Orsay virus 
RNA compared to N2 (Figure 4.6) [16]. The VC20199 strain also had higher Orsay virus RNA 
when infected at a lower MOI of 0.1. However, it was not statistically significant 
(Supplementary Figure 4.2). This result suggests that zip-1 may have an antiviral effect. 
However, mutants from the Million Mutation Project contain additional mutations to the genome 
[8]. Specifically, the VC20199 contains a missense mutation to the drh-1 gene which is essential 
for the sensing of viral RNA for downstream antiviral RNAi pathway (Supplementary Table 3) 
[2,14]. The specific mutations was an A250T amino acid change on the DRH-1 isoform A. To 
exclude the possibility that the Orsay virus replication phenotype was due to the exo-RNAi 
pathway, we conducted a feeding RNAi test with dpy-3 and found VC20199 was competent in 
exo-RNAi as the worms displayed a strong dumpy phenotype (Data were not shown). These 
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results suggest that the VC20199 strain contains mutations that were antiviral in nature, however, 
the contributing mutations may be zip-1, drh-1, or other mutations. 
 
Figure 4.6: Orsay virus replication in knockout mutants from the 58 conserved DEGs. 20 
mutants that contain knockout mutations of the 58 conserved virus DEGs were infected by Orsay 
virus at an MOI of 10 for two days. The Orsay virus RNA was measured by qRT-PCR. The three 
control conditions used were the input virus, infection of N2 and rde-1 strains. The individual 
value, the geometric mean, and the 95% CI are shown. Statistical significance was assessed 
using Kruskal-Wallis test with Dunn’s post hoc test against N2. *P < 0.05.   
 
I next tested the seven strains from CGC that had mutations from the list of 58 
evolutionarily conserved DEGs. After infection with Orsay virus, two strains had statistically 
different Orsay virus RNA amount from the N2 control (Figure 4.7A). Interestingly, the two 
strains with hmit-1.1 and zip-10 mutations were lower than N2, suggesting that they were 
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putative proviral genes. The strain with sid-5 mutation also had a lower amount of Orsay virus 
RNA and was statistically lower than N2 when compared individually but not after correction for 
multiple comparisons. The three genes have annotated functions, hmit-1.1 is a H+/myo-inositol 
transporter gene [17], zip-10 is a bZIP transcription factor [16,18], and sid-5 is endosome-
associated protein required for systemic RNAi [19]. The seven strains were also evaluated for the 
production of infectious Orsay virus by the end-point dilution assay. I found that while hmit-1.1, 
zip-10, and sid-5 all had lower TCID50/ml than N2, only hmit-1.1 was statistically significant 
(Figure 4.7B). Since there was ambiguity for the sid-5 and zip-10 mutants, I conducted more 
experiments along with hmit-1.1 to confirm the phenotype. I found that the hmit-1.1 mutant did 
not reproduce the phenotype we initially observed (Figure 4.8A & 4.8B). However, sid-5 and 
zip-10 had the statistically lower amount of Orsay virus RNA than N2 control (Figure 4.8A). zip-
10 mutant also had statistically lower infectious Orsay virus than N2 (Figure 4.8B).  
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Figure 4.7. Screening of the mutants (CGC) with mutations for the evolutionarily 
conserved DEGs. Strains with evolutionarily conserved DEG mutants were infected with Orsay 
virus at an MOI of 10 for five days. A) The Orsay virus RNA was measured by qRT-PCR. B) 
The amount of infectious Orsay virus was measured by end-point dilution assay. The three 
control conditions used were the input virus, infection of N2 and rde-1 strains. The individual 
value, the geometric mean, and the 95% CI are shown. Statistical significance was assessed 
using Kruskal-Wallis test with Dunn’s post hoc test against N2. *P < 0.05, **P < 0.005.   
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Figure 4.8. Screening of the mutants (CGC) with mutations for the evolutionarily 
conserved DEGs. 500 animals from each strain with evolutionarily conserved DEG mutants 
were infected with Orsay virus at MOI 10 for three days. A) The Orsay virus RNA was measured 
by qRT-PCR. B) The amount of infectious Orsay virus was measured by end-point dilution 
assay. The three control conditions used were the input virus, infection of N2 and rde-1 strains. 
The individual value, the geometric mean, and the 95% CI are shown. Statistical significance 
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was assessed using Kruskal-Wallis test with Dunn’s post hoc test against N2. *P < 0.05, **P < 
0.005.  ***P < 0.0005.   
 
I next crossed the three strains into the rde-1 background to determine if the mutations 
influenced Orsay virus replication without functional antiviral RNAi. After infecting the mutants 
with Orsay virus, we found that only zip-10 mutant in the rde-1 background was statistically 
lower than rde-1 (Figure 4.9).  
 
Figure 4.9: Orsay virus replication in mutants crossed into the rde-1 background. The three 
mutants hmit-1.1, sid-5, and zip-10 were crossed into rde-1 mutant to make the high virus 
permissive strains. All strains were infected with Orsay virus and the amount of virus replication 
measured by both qRT-PCR. The three control conditions used were the input virus, infection of 
N2 and rde-1 strains. The individual value, the geometric mean, and the 95% CI are shown. 
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Statistical significance was assessed using Kruskal-Wallis test with Dunn’s post hoc test against 
N2. *P < 0.05. 
 
In summary, after screening a total of 27 mutants that contain mutations from the list of 
58 evolutionarily conserved DEGs, we found the strain VC20199 with zip-10 mutation have 
antiviral properties. I also found zip-10 mutant that reduced Orsay virus replication and acts in 
the proviral fashion.  
Discussion and Conclusion 
 
With the recent discovery of its naturally infecting Orsay virus, C. elegans has became an 
excellent model organism to investigate host-virus interactions [1]. We can now interrogate the 
C. elegans – Orsay virus model system to better understand the host-virus interactions. With the 
available genetic tools in C. elegans and the assays we developed in the Wang lab, I have 
systematically screened the evolutionarily conserved DEGs for genes that may influence Orsay 
virus replications.  
The overexpression strains were derived from a forward genetic screen with an integrated 
GFP reporter strain ERT54 jyIs8 [pC17H1.6::GFP; pmyo-2::mCherry]; both strains turned on 
the GFP reporter constitutively. Interestingly, the causal mutation has been mapped to the 
C29F2.1, a member of the C17H1 gene family that was not up-regulated upon virus infection 
(personal communication with Emily Troemel). However, one limitation of this approach was 
that the full set of genes regulated by C29F2.1 was unclear. Nonetheless, defining the Orsay 
virus replication phenotype in JY1 and JY3 can help us understand that if the C29F2.1 regulated 
genes that include several virus DEGs are involved in host-virus interactions. JY1 and JY3 had 
significantly lower Orsay virus in the MOI 0.1 condition, suggesting a protective phenotype, 
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However, the phenotype is not observed in the MOI 10 condition, this suggest that the protective 
effect is not robust and can be masked by high tier infection. Because it is not possible to rule out 
the possibility of non-viral DEGs attributing to the observed phenotype, further investigation is 
needed. 
One important genetic tool in C. elegans is the sliencing of trasnscript by feeding RNAi. 
The feeding RNAi is an efficient way to konckdown gene expression, however, there are some 
challenges to feeding RNAi, such as not 100% knockdown of mRNA and potential competition 
between exo-RNAi and antiviral RNAi [2,9,13]. The feeding RNAi of GFP in the N2 GFP 
reporter worms resulted in more Orsay virus RNA. This result suggested that there was indeed 
competition between the exo-RNAi and antiviral RNAi as GFP should not influence Orsay virus 
replication. In both the N2 background and drh-1 background, no RNAi knockdown produced a 
statistically significant change from the control. It is possible that the limitation of RNAi 
confounded the results, or it is also possible that indeed none of these genes were not related to 
the host-virus interactions.  
The C17H1 gene family has a human ortholog, ALSCR12 but both the human orthologs 
and the C17H1 gene family have no known functions. Multiple individual genes were examined 
from the RNAi knockdown screen and none of the genes influenced Orsay virus replication. One 
possible explanation was that the C17H1 genes have a weak interaction with Orsay virus 
replication and that the limitation of RNAi knockdown was not able to provide conclusive 
results. Another possibility was that there may be redundancy to the C17H1 gene family, 
therefore, knocking down individual genes did not change the Orsay virus replication phenotype.  
From the stable mutant screen, I have found that T27E7.6 and zip-1 appeared to be 
antiviral genes. However, it is possible that the casual mutations were not the two gene, 
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especially zip-1 as the mutant strain also had a mutation important for Orsay virus infection in 
drh-1. There were multiple independent experiments for hmit-1.1, sid-3, and zip-10. There were 
conflicting results for the hmit-1.1 mutant. Since only one out of the three experiments showed 
that hmit-1.1 mutant had lower Orsay virus replication and the two other experiments did not, 
hmit-1.1 most likely was not involved the host-virus interactions. The sid-5 mutant had 
consistent lower Orsay virus replication in all three independent experiments but only have one 
experiment statistically lower than N2. These results suggest that it is possible that sid-5 play a 
minor role in host-virus infection. However, it is also possible that sid-5 was not involved Orsay 
virus replication and that the one statistically significant results occurred by chance. Lastly, the 
zip-10 mutant also consistently had lower Orsay virus replication phenotype in all three 
experiments and was statistically significant in all but one assay. These results suggest that zip-
10 played a role in the host-virus interactions and given the mutant had lower Orsay virus 
replication, zip-10 most likely acts in a proviral fashion. To confirm that these candidate genes 
were indeed part of the host-virus interactions, further experiments should be conducted. 
 In conclusion, I have found 2 strong candidate genes that interacts with Orsay virus 
infection in T27E7.6 and zip-10. These two genes were not implicated in any virus infections 
previously and could be novel host pathways that interacts with the Orsay virus.  
Materials and Methods 
 
Worm strains 
C. elegans strains N2, and rde-1 (WM27) along with C. briggsae strain AF16 were obtained 
from the Caenorhabditis Genetics Center (CGC). The GFP reporter strain ERT54 jyIs8 
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[pC17H1.6::GFP; pmyo-2::mCherry] was kindly provided by Emily Troemel [3]. Additional 
strains used for screening were listed in Supplementary Table 1.  
CRISPR knockout in C elegans 
To make a 35kb C17H1 region deletion mutant (WUM6), we used a coconversion strategy 
described by Arribere et al. (2014) with a dpy-10 sgRNA as the selection marker. We first 
constructed the short guide RNA (sgRNA) plasmids (C17H1.3_sg2 and C17H1.7_sg2) by 
designing the sgRNA (5’-gaacagagtgaagcaggaag-3’) to target C17H1.3 and sgRNA (5’-
acgggcagatatacagagac-3’) to target C17H1.7. The short oligonucleotides were synthesized (IDT), 
annealed and ligated into a modified version of DR274 (Addgene Plasmid #42250) where the 
sgRNA site was flanked by BsaI and C. elegans U6 promoter and terminator from pU6::klp-
12_sgRNA (Addgene #42250) (Gift from Michael Nonet). The constructed sgRNA expression 
plasmids (20 ng/uL each) were co-injected into N2 worms with C17H1 region single stranded 
donor DNA (5’-
attttgctcttatcacatttatagaaatgacaaaagtcaccgagccctcggtttttctttgcgatagttcagagcttctcaaatctctca-3’) 
(500nM), pDD162 (Addgene Plasmid #47549) that expressed Cas9 with empty sgRNA 
(50ng/uL), dpy-10(cn64) single stranded donor DNA (500nM), and dpy-10(cn64) sgRNA (20 
ng/uL). Dumpy or roller F1s were selected to ensure that all CRISPR/Cas9 were expressed and 
dpy-10 was successfully modified. Worms were subsequently genotyped for the deletion with 
single worm 3-primer PCR where a primer pair flanking the whole deletion region and a third 
primer in the proposed deleted region (GW503 (5’-gttagaaatgcgctgtgacgt-3’), GW504, (5’-
agctcgctcagcattgttg-3’), GW515 (5’-ggaatggtactaccagtgctg-3’)). The dpy-10 animal was crossed 
with N2 to obtain the final ~34kb deletion mutant strain without the dumpy phenotype. 
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Worm infection on solid medium 
Uninfected C. elegans (N2 and rde-1) and uninfected C. briggsae (AF16) were synchronized by 
standard bleach treatment. 500 embryos were seeded per well into 6-well NGM plates containing 
20-30 μl of OP50 food and maintained at 20°C. 16 hours after bleaching; worms were inoculated 
by adding 20 μl of Orsay virus of starting at 2.5 x 105 TCID50 /ml for an MOI of ~10 directly 
over the bacterial lawn. Lower MOI infection conditions were obtained by additional 10-fold 
dilution of the starting Orsay virus stock. After 2 days or 3 days post-infection, animals were 
rinsed off from the wells with 1 ml M9 buffer, the supernatant was removed after centrifugation, 
and 350 ul Trizol were added to the samples. 
 
RNAi feeding knockdown infection on solid medium 
RNAi feeding was used for gene knockdown as described [9].  E. coli strain HT115 
carrying double strand RNA expression cassettes for genes of interest were induced using 
established conditions and were then seeded into 6-well NGM plates. Empty vector, rde-1 RNAi 
clones were from the Ahringer RNAi library [20]. 500 arrested GFP reporter animals were 
seeded into each well of a 6-well plate. After 2 days of RNAi feeding, Orsay virus was added to 
the plates as described with solid medium infection. After 2-day infection, the infected C. 
elegans animals were collected as described with solid medium infection. 
 
Measuring Orsay virus RNA by real-time quantitative one-step RT-PCR (qRT-PCR 
Infected worm samples in Trizol were vortexed for 10 minutes at room temperature and 
centrifuged at 15,000g for 5 minutes. The Trizol supernatants were extracted with Direct-zol 
RNA miniprep kit (Zymo) and eluted into 60 μl water. The extracted samples were diluted 1:100 
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and 5 μl of the diluted RNA were used for one-step real-time RT-PCR (Fast virus Thermo-
fisher). Real-time qPCR was performed using Taqman qPCR master mix reagents (Applied 
Biosystem) on a ViiA7 real-time PCR system (Applied Biosystem) following the manufacturer’s 
suggested protocol. The copy number for each sample were calculated from a standard curve and 
were normalized to an internal control cdc-42 gene. 
 
Measuring Orsay virus titer with reporter infection assay 
To measure the infectious titer of viruses, we employed a method similar to tissue culture 
infectious dose 50% (TCID50) using live C. elegans or C. briggsae in wells instead of cultured 
cells. We were not able to measure killing of nematodes as none of the viruses were lethal. To 
measure infectivity in a well, we used the GFP reporter strain ERT54 jyIs8 to determine whether 
replication of viral RNA occurred by the GFP signal. Briefly, the GFP reporter worms were 
synchronized and 50 worms were plated to each well on a 96-well plate seeded with 20 l 50x 
concentrated OP50. Virus filtrates were serially diluted 10-fold to 10-5. 20 l of each dilution 
were added to each well containing animals and combined to have four total replicates per 
condition. Infected animals were incubated at 20°C for three days shaking @ 150 RPM. All 
wells were anesthetized by a final concentration of 20 nM sodium azide, and the GFP 
fluorescence of the well was scored with Cytation 3 (BioTek). A well has more than two worms 
positive with GFP was considered a positive infection. TCID50 were then calculated using the 
Spearman and Karber algorithm.  
 
Measuring Orsay virus titer with reporter infection assay 
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To measure the infectious titer of viruses, we employed a method similar to tissue culture 
infectious dose 50% (TCID50) using live C. elegans or C. briggsae in wells instead of cultured 
cells. We were not able to measure killing of nematodes as none of the viruses were lethal. To 
measure infectivity in a well, we used the GFP reporter strain ERT54 jyIs8 to determine whether 
replication of viral RNA occurred by the GFP signal. Briefly, the GFP reporter worms were 
synchronized, and 50 worms were plated to each well on a 96-well plate seeded with 20 l 50x 
concentrated OP50. Virus filtrates were serially diluted 10-fold to 10-5. 20 l of each dilution 
were added to each well containing animals and combined to have four total replicates per 
condition. Infected animals were incubated at 20°C for three days shaking at 150 RPM. All wells 
were anesthetized by a final concentration of 20 nM sodium azide, and the GFP fluorescence of 
the well was scored with Cytation 3 (BioTek). A well has more than two worms positive with 
GFP was considered a positive infection. TCID50 were then calculated using the Spearman and 
Karber algorithm [14].  
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Supplementary Materials 
 
Supplementary Figure 4.1. Screening of C17H1 gene family member mutants for Orsay 
virus replication with low MOI infection. Mutants containing C17H1 gene family members 
were infected with Orsay virus at an MOI of 0.1 for two days. The Orsay virus RNA was 
measured by qRT-PCR. The three control conditions used were the input virus, infection of N2 
and rde-1 strains. The individual value, the geometric mean, and the 95% CI are shown. 
Statistical significance was assessed using Kruskal-Wallis test with Dunnett’s Multiple 
Comparisons Test against N2. 
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Supplementary Figure 4.2: Orsay virus replication in knockout mutants from the 58 
conserved DEGs with lower MOI. 20 mutants that contain knockout mutations of the 58 
conserved virus DEGs were infected by Orsay virus at an MOI of 0.1 for 2 days. The Orsay virus 
RNA was measured by qRT-PCR. The three control conditions used were the input virus, 
infection of N2 and rde-1 strains. The individual value, the geometric mean, and the 95% CI are 
shown. Statistical significance was assessed using Kruskal-Wallis test with Dunnett’s Multiple 
Comparisons Test against N2. No mutants were statistically different from N2. 
 
 
 
 
 
Supplementary Table 4.1. Mutant strains used. 
Sequence  Gene  Strain  Type 
C17H1 gene family members   
C54D10.8  C54D10.8  VC20072 nonsense 
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C54D10.14  C54D10.14  VC20366 intron, splicing 
Y57G11B.1  Y57G11B.1  VC40434 intron, splicing 
T27E7.6  T27E7.6  VC40577 intron, splicing 
W08A12.4  W08A12.4  VC40612 nonsense 
Evolutionarily conserved DEGs (Million Mutation Project) 
Y75B8A.35a  zip‐1  VC20199 deletion, frame shift 
Y58A7A.3  Y58A7A.3  VC20399 intron, splicing 
B0507.6  B0507.6  VC20427 intron, splicing 
B0457.6  B0457.6  VC40007 deletion, frame shift 
F49E12.2  dod‐23  VC40063 intron, splicing 
C49G7.5  irg‐2  VC40096 intron, splicing 
K10H10.9  K10H10.9  VC40140 deletion, frame shift 
F53H2.1  F53H2.1  VC40146 nonsense 
F15H10.9  F15H10.9  VC40209 start ATG 
C49G7.10  C49G7.10  VC40358 nonsense 
B0507.9  B0507.9  VC40388 intron, splicing 
F15B9.6  F15B9.6  VC40517 nonsense 
Y47G7B.2  Y47G7B.2  VC40608 intron, splicing 
F42C5.3  F42C5.3  VC40701 nonsense 
F14B8.2  F14B8.2  VC40799 start ATG 
Y6E2A.5  Y6E2A.5  VC40816 nonsense 
ZK177.8a  ZK177.8  VC40866 nonsense 
F14F9.4  F14F9.4  VC40934 nonsense 
ZC196.3  ZC196.3  VC40951 intron, splicing 
K09D9.1  K09D9.1  VC40974 nonsense 
Evolutionarily conserved DEGs (CGC) 
C04F12.1  C04F12.1  WM153  deletion, frame shift 
Y51A2D.4  hmit‐1.1  RB2163  deletion, frame shift 
F14B8.2  sid‐5  RB2536  deletion, frame shift 
C34D1.5  zip‐5  TM2038  deletion, frame shift 
T27F2.4  zip‐10  RB2499  deletion, frame shift 
T24B8.5  T24B8.5  VC2477  deletion, frame shift 
Y58A7A.3  Y58A7A.3  RB2449  deletion, frame shift 
 
 
 
Supplementary Table 4.2. Mutations in VC40577 strain. 
Gene Allele Mutation Effect Type 
ain-2 gk702316 T->C affects 
splicing 
intron, splicing 
let-363 gk702319 T->A N1241K missense 
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unc-82 gk702515 C->T A115V missense 
cdc-48.1 gk961350 3741N->  deletion, across exon 
boundary 
str-250 gk702588 C->T L294F missense 
pro-2 gk702392 T->C M258V missense 
C08F1.6 gk702357 G->A A12V missense 
unc-89 gk702311 T->C F5703L missense 
C16A3.4 gk702450 C->T A19V missense 
pbrm-1 gk702326 C->T P668S missense 
syg-2 gk702675 T->A Y759stop nonsense 
C35C5.6 gk702662 C->T P1215S missense 
lact-7 gk702663 G->A G155R missense 
cps-6 gk702314 T->C D291G missense 
set-5 gk702591 C->T P865S missense 
C50E3.5 gk702574 C->T T391I missense 
mpz-1 gk702398 T->C D1725G missense 
ceh-17 gk702315 G->A T157I missense 
D1043.1 gk702405 A->T K886stop nonsense 
D1081.9 gk702332 G->A S179F missense 
E01G6.2 gk702666 T->A F74I missense 
din-1 gk702406 G->A P->L missense 
str-111 gk702597 T->A E197D missense 
F15E11.15 gk702563 C->T G157E missense 
srd-46 gk702667 C->T T148M missense 
F20D6.5 gk702576 C->T P335L missense 
asp-5 gk702577 T->C L199P missense 
F21G4.6 gk702656 T->G M115L missense 
jmjd-3.2 gk702673 T->C L630P missense 
F25B3.5 gk702580 C->T E321K missense 
F28C6.1 gk702383 G->A R174Q missense 
F28C6.5 gk702384 G->A D89N missense 
lrp-1 gk702328 T->G V2684G missense 
F32B6.9 gk702522 G->A W141stop nonsense 
F32D1.3 gk702567 C->T G692E missense 
nhr-37 gk702573 C->T P130L missense 
F44F4.1 gk702399 C->T P34S missense 
F49C5.12 gk702412 G->A A4V missense 
acl-4 gk702632 C->T G426E missense 
pqe-1 gk702448 C->T H317Y missense 
F53A2.7 gk702488 G->A G168D missense 
mtm-6 gk702489 C->T P33S missense 
109 
 
F53H2.1 gk702621 C->A Q713K missense 
F53H2.1 gk702622 G->A Q713K missense 
F53H2.1 gk702623 A->T R738S missense 
rog-1 gk702355 C->T G479R missense 
F58E6.13 gk702581 C->T P183L missense 
math-32 gk702358 G->A G260D missense 
scl-13 gk702566 C->T A72T missense 
H12D21.6 gk702592 C->T G94E missense 
K05C4.3 gk702353 C->T E27K missense 
aptf-1 gk702374 G->A R35K missense 
K07A1.5 gk702337 C->T A81V missense 
gpd-3 gk702634 C->T R329K missense 
smo-1 gk702291 G->A S54N missense 
K12H6.5 gk702360 G->A P22S missense 
R119.2 gk702282 G->A R178C missense 
vet-1 gk702322 A->C D112E missense 
rps-24 gk702495 G->A V4I missense 
rmd-5 gk702323 C->T P239S missense 
T23F1.3 gk702595 C->T G14E missense 
T27E7.6 gk702541 C->T affects 
splicing 
intron, splicing 
T28C6.7 gk702518 C->T S1976L missense 
afd-1 gk702300 G->A V165I missense 
twk-33 gk702605 T->A I125F missense 
twk-33 gk702606 A->C Y119stop nonsense 
mig-1 gk702286 C->T D453N missense 
Y39C12A.1 gk702528 C->T C123Y missense 
bre-2 gk702486 G->A A304V missense 
xrn-1 gk702428 G->A R646Q missense 
snrp-200 gk702414 G->A P2051S missense 
gcn-1 gk702438 C->T A162V missense 
Y51F10.10 gk702297 G->A A163V missense 
Y54E2A.4 gk702430 G->A E1844K missense 
fbxa-219 gk702440 C->T S201F missense 
Y55B1BR.2 gk702432 C->T H561Y missense 
Y57A10A.27 gk702409 G->A L315F missense 
Y59C2A.3 gk702359 G->A P327L missense 
ptr-21 gk702284 G->A V236I missense 
Y69A2AR.7 gk702501 C->T R181C missense 
aqp-3 gk702524 C->T E331K missense 
Y71G12B.25 gk702295 G->A T45I missense 
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srv-13 gk702510 C->A T264N missense 
Y75B8A.13 gk702475 C->A V449F missense 
Y75B8A.13 gk702476 G->A A446V missense 
Y87G2A.2 gk702347 C->T L184F missense 
ZC455.1 gk702585 C->T P183L missense 
ubq-2 gk702483 C->T G53R missense 
ZK688.3 gk702455 C->T R8C missense 
ZK863.4 gk702584 C->T A612T missense 
 
Supplementary Table 4.3. Mutations in VC20199 strain. 
Gene Allele Mutation Effect Type 
rpia-1 gk177878 G->A V48I missense 
arrd-25 gk300064 T->C C174R missense 
srsx-18 gk236191 C->T P199S missense 
C05B5.17 gk183203 G->A A97V missense 
C07E3.3 gk152692 T->G D282A missense 
C17E4.6 gk118735 G->A R33Q missense 
C27D9.1 gk141511 G->A V37I missense 
C33A11.1 gk303215 C->T S513F missense 
C34D10.2 gk286563 T->A M565K missense 
stam-1 gk111998 G->A P424L missense 
C48B6.9 gk113945 T->C T15A missense 
tag-333 gk254472 G->A T737I missense 
scrt-1 gk105446 G->A G118D missense 
F07F6.4 gk142911 C->T A294T missense 
F09C8.1 gk305123 C->T G134R missense 
F09E5.10 gk315212 C->T G581R missense 
F09G8.5 gk179828 G->A G269S missense 
emb-27 gk148369 C->T A439T missense 
F13A7.1 gk257921 C->T A330T missense 
drh-1 gk204047 C->T A250T missense 
him-4 gk290282 C->T P1577L missense 
srh-92 gk239386 C->T M159I missense 
F28C10.3 gk269286 C->T G161E missense 
akt-2 gk300327 C->T P75S missense 
nac-1 gk302130 G->A A85T missense 
ags-3 gk280162 C->T R493Q missense 
F33H2.8 gk130561 G->T L130I missense 
npr-7 gk289341 C->T D352N missense 
gst-24 gk159943 C->T R131Q missense 
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nas-39 gk305825 C->T A790V missense 
F38E9.6 gk952675 CA->C  deletion, frame shift 
F40H3.1 gk144430 T->A C447S missense 
cyp-33C3 gk228633 C->T A445V missense 
F41C3.5 gk141473 G->A A344T missense 
tbc-18 gk287318 C->T R605C missense 
F41G3.2 gk145604 C->T L74F missense 
clec-119 gk133331 C->T A47V missense 
F48E3.8 gk285385 C->T G954E missense 
F53F8.5 gk267729 G->T P299Q missense 
F55F8.3 gk111542 C->T V208I missense 
srz-19 gk199039 C->T L299F missense 
btb-20 gk162064 C->T D251N missense 
faah-3 gk193118 T->G H418S missense 
faah-3 gk193119 G->A H418S missense 
H01M10.1 gk273859 C->T G147E missense 
H03A11.2 gk302915 C->T E1212K missense 
pms-2 gk247737 C->T affects 
splicing 
intron, splicing 
ttr-1 gk183053 G->A D60N missense 
K06A1.2 gk145010 T->A F292I missense 
K06G5.1 gk300503 G->A G172D missense 
K10F12.6 gk164534 G->A A89V missense 
K12H6.12 gk136942 C->T T261I missense 
M02G9.1 gk152658 C->T P378S missense 
nhr-99 gk224611 C->T P71L missense 
R03G8.6 gk297828 C->T V627M missense 
R04A9.7 gk268952 C->G S341T missense 
ech-4 gk153777 C->T A208V missense 
R11A8.5 gk210682 C->T A340T missense 
atl-1 gk243777 C->T M1019I missense 
unc-50 gk183862 G->A T270I missense 
ucr-2.2 gk302795 C->T A360V missense 
glh-4 gk107809 G->A G416E missense 
aat-4 gk203428 C->T affects 
splicing 
intron, splicing 
spat-3 gk278486 C->T E1174K missense 
T19D12.2 gk145401 A->C N330H missense 
T21B10.4 gk149876 C->T R265C missense 
T23F11.2 gk173194 T->C I193V missense 
T26C12.2 gk197673 C->T A17T missense 
haf-4 gk101015 G->A S233N missense 
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W07G1.1 gk160708 C->T V222M missense 
W09C5.1 gk127467 G->A A113V missense 
nkcc-1 gk217690 C->T V->I missense 
Y37D8A.4 gk189192 G->A R7C missense 
Y38E10A.22 gk157775 T->A Y193F missense 
Y39B6A.1 gk264044 G->A H667Y missense 
Y39E4A.3 gk189510 G->A L317F missense 
col-96 gk186769 G->A P160S missense 
Y48E1A.1 gk160133 C->T D1599N missense 
Y51H1A.2 gk160512 C->T R768Q missense 
srh-42 gk161601 C->T E156K missense 
Y56A3A.7 gk187251 T->G D270A missense 
Y57A10A.4 gk156680 C->T P416S missense 
csn-1 gk261258 C->T M464I missense 
Y73C8C.10 gk230096 T->C D379G missense 
zip-1 gk944976 CA->C  deletion, frame shift 
lron-13 gk190679 G->A V574M missense 
Y8A9A.2 gk139244 C->T A87V missense 
ZC449.1 gk279542 A->G K200E missense 
ZC487.1 gk237879 C->T P69S missense 
ZC84.6 gk181606 G->A A1405V missense 
ZK1010.2 gk189529 C->T R249Q missense 
nep-1 gk155586 C->T D88N missense 
pgl-1 gk204608 C->T E16K missense 
ZK470.6 gk277524 C->T C88Y missense 
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Chapter 5: Discussion and Conclusion 
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 With the discovery of viruses that naturally infect Caenorhabditis nematodes, C. elegans 
has become a great model organism to study host-virus interactions. The transcriptional profiling 
study of both virus and microsporidium infection provided insights into the host response to 
pathogens. We found that distinct pathogens such as Orsay virus and N. parisii elicited a similar 
set of DEGs in C. elegans, suggesting that these DEGs may constitute a broad pan-microbial 
response to infection. Additionally, within the transcriptional profile of viral infection in the two 
different nematode species C. elegans and C. briggsae, we found a shared set of 58 
evolutionarily conserved transcriptional responsive genes to viral infection, many of which have 
no known function. Given the fact that diverse hosts regulate these common genes in response to 
distinct viral infections suggests that they play important roles.  
Characterizing how Orsay virus replicates in C. elegans is an important precursor to 
studying host-virus interactions. One interesting finding was that the laboratory reference strain 
N2 was highly variable, especially in the low MOI conditions (MOI < 1). I also found that the 
liquid culture infection did not reduce variation in the similar MOI. The high variation in N2 
may indeed indicate that the host-virus interaction relies on some stochastic process that were yet 
to be defined. I found that the process of feeding RNAi may compete with antiviral RNAi, 
therefore, proper control is required when interpreting results of Orsay virus replication from 
RNAi knockdown experiments. 
I used the available genetic tools including feeding RNAi and knockout mutants to 
determine if the 58 evolutionarily conserved DEGs directly interact with Orsay virus. From the 
feeding RNAi assays we did not found any of the 58 DEGs to be influencing Orsay virus 
replication. One limitation of feeding RNAi knockdown is the inability to completely abolish the 
expression of the targeted genes. Another limitation would be the competition between the 
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feeding RNAi and the antiviral RNAi. With these limitations, a non-robust phenotype from the 
feeding RNAi experiments could imply either a weak interaction or no interactions with Orsay 
virus. However, with genes that have important roles in the host-virus interactions, feeding RNAi 
still functions as a good method to efficiently screen large number of genes. 
From the screening of stable mutants, I had found that T27E7.6 and zip-1 appeared to be 
antiviral genes whereas zip-10 likely played a proviral role. All three mutants containing the 
specified mutation have reproducible and strong change to Orsay virus replication. None of the 
three genes were previously known to be associated with virus replication, suggesting that these 
genes may represent completely novel host-virus interactions. However, given that these mutants 
were generated from chemical mutagenesis, other mutations exist in these strains and may be 
responsible for the observed phenotype. This was especially true for the strain with zip-1 
mutation as it contains another mutation in drh-1, which is an important antagonist of Orsay 
virus infection. Downstream experiments such as generating clean knockout of these genes with 
CRISPR/Cas9 and transgenic rescue of the worms are needed to determine the true causal 
mutations. 
Collectively, the identification of the virus response genes, the development of assays to 
efficiently and reliably determine Orsay virus replication phenotypes, and the discovery of genes 
that alter Orsay virus infection of C. elegans provide a foundation for future studies of host virus 
interactions in this model system. 
